US20110029064A1 - Flexible stent - Google Patents

Flexible stent Download PDF

Info

Publication number
US20110029064A1
US20110029064A1 US12/884,514 US88451410A US2011029064A1 US 20110029064 A1 US20110029064 A1 US 20110029064A1 US 88451410 A US88451410 A US 88451410A US 2011029064 A1 US2011029064 A1 US 2011029064A1
Authority
US
United States
Prior art keywords
stent
helical
strut
portions
elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/884,514
Inventor
Janet Burpee
Bradley Beach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/884,514 priority Critical patent/US20110029064A1/en
Publication of US20110029064A1 publication Critical patent/US20110029064A1/en
Priority to US14/303,766 priority patent/US9592137B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates generally to expandable tubular structures capable of insertion into small spaces in living bodies and, more particularly, concerns a stent structure which is capable of substantial and repeated flexing at points along its length without mechanical failures and with no substantial changes in its geometry.
  • a stent is a tubular structure that, in a radially compressed or crimped state, may be inserted into a confined space in a living body, such as an artery or other vessel. After insertion, the stent may be expanded radially to enlarge the space in which it is located. Stents are typically characterized as balloon-expanding (BX) or self-expanding (SX).
  • BX balloon-expanding
  • SX self-expanding
  • a balloon-expanding stent requires a balloon, which is usually part of a delivery system, to expand the stent from within and to dilate the vessel.
  • a self expanding stent is designed, through choice of material, geometry, or manufacturing techniques, to expand from the crimped state to an expanded state once it is released into the intended vessel. In certain situations higher forces than the expanding force of the self expanding stent are required to dilate a diseased vessel. In this case, a balloon or similar device might be employed to aid the expansion
  • Stents are typically used in the treatment of vascular and non-vascular diseases. For instance, a crimped stent may be inserted into a clogged artery and then expanded to restore blood flow in the artery. Prior to release, the stent would typically be retained in its crimped state within a catheter and the like. Upon completion of the procedure, the stent is left inside the patient's artery in its expanded state. The health, and sometimes the life, of the patient depend upon the stent's ability to remain in its expanded state.
  • stents are flexible in their crimped state in order to facilitate the delivery of the stent, for example within an artery. Few are flexible after being deployed and expanded. Yet, after deployment, in certain applications, a stent may be subjected to substantial flexing or bending, axial compressions and repeated displacements at points along its length, for example, when stenting the superficial femoral artery. This can produce severe strain and fatigue, resulting in failure of the stent.
  • stent-like structures A similar problem exists with respect to stent-like structures.
  • An example would be a stent-like structure used with other components in a catheter-based valve delivery system. Such a stent-like structure holds a valve which is placed in a vessel.
  • a stent or a stent-like structure is constructed to have different types of tubular portions along its length.
  • there are strut portions and helical portions where the strut portions are constructed primarily to provide radial expansion and radial strength, and the helical portions are constructed primarily to permit repeated flexing and axial compression and expansion.
  • the flexing and axial compression are likely to be required simultaneously, so the stent structure permits repeated and substantial flexing while in an axially compressed or expanded state, and it permits axial compression while in a flexed state.
  • strut portions are provided between helical portions or helical portions are provided between strut portions.
  • the stent is self-expanding and strut portions and helical portions alternate along the length of the stent.
  • the stent is preferably constructed so that, in the expanded state the helical portions permit axial compression or expansion of about 20% (preferably between 15% and 25%) and simultaneously permit bending with a minimum bending radius of about 13 mm (preferably between 10 mm and 16 mm).
  • a helical portion is made of helical elements which extend helically about the axis of the stent between points on two different strut portions which are spaced apart circumferentially by a distance which is more than approximately 25% of the circumference of the stent (which is equivalent to an extent of 90 degrees about the axis of the stent) when it is in its expanded state.
  • a helical portion is made of helical elements which extend helically about the axis of the stent between locations on two different strut portions.
  • a helical element is bi-directional, in that it extends first in one circumferential direction and then the other between the two locations and has a peak.
  • a stent has a plurality of axially spaced strut portions defining generally tubular axial segments of the stent and constructed to be radially expandable.
  • a helical portion is interposed axially between two strut portions, and the helical portion has a plurality of helical elements connected between circumferentially spaced locations on two strut portions.
  • a helical element extends helically between these locations, and at least part of the helical portion has a greater diameter than a strut portion when the stent is in an expanded state.
  • at least part of the helical portion has a smaller diameter than the strut portion when the strut is in an expanded state.
  • the helical element is wound at least 90 degrees between strut elements connected to the helical element. In another embodiment, the helical element is wound at least 360 degrees between strut elements connected to the helical element.
  • stent grafts are formed of a biocompatible graft material covering the outside, inside or both the outside and inside of the stent.
  • the stent graft can have any embodiment of a stent structure of the present invention.
  • Stent graft devices are used, for example, in the treatment of aneurysms, dissections and tracheo-bronchial strictures.
  • the stent can also be coated with a polymer and/or drug eluting material as are known in the art.
  • FIG. 1A is a plan view of a first embodiment of a stent in accordance with the present invention, the stent being shown in an unexpanded state;
  • FIG. 1B is a plan view of the first embodiment of a stent in accordance with the present invention, the stent being shown in a radially expanded state;
  • FIG. 2 is a plan view of a second embodiment of a stent in accordance with the present invention.
  • FIG. 3 is a plan view of a third embodiment of a stent in accordance with the present invention.
  • FIG. 4 is a plan view of a fourth embodiment of a stent in accordance with the present invention.
  • FIG. 5 is a sectional end view of a fifth embodiment of a stent in accordance with the present invention.
  • FIG. 6 is a lengthwise side outline view of the same embodiment as FIG. 5 ;
  • FIG. 7A is a plan view of another embodiment of a stent in accordance with the present invention.
  • FIG. 7B is a plan view of another embodiment of the stent in accordance with the present invention.
  • FIG. 8 is a sectional end view of another embodiment of the stent in accordance with the present invention.
  • FIG. 9 is a lengthwise side outline view of the embodiment shown in FIG. 8 ;
  • FIG. 10A is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an outer surface of the stent;
  • FIG. 10B is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an inner surface of the stent;
  • FIG. 10C is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an outer surface and an inner surface of the stent;
  • FIG. 11A is a side view of an alternate embodiment of a stent in accordance with the present invention including graft material attached to the strut portion, the graft material covering the strut portion and the helical portion;
  • FIG. 11B is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material wherein a gap is provided between each of the sections of graft material;
  • FIG. 11C is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of a biocompatible graft material wherein the graft material of adjacent sections is overlapped;
  • FIG. 11D is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material, the graft material having a bulge at the helical portions;
  • FIG. 11E is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material, the graft material having a plurality of longitudinal openings over the helical portions;
  • FIG. 11F is a side view of an alternate embodiment of a stent in accordance with the present invention the graft material having a bulge at the helical portions and the graft material having a plurality of longitudinal openings over the helical portions;
  • FIG. 11G is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material having a plurality of helical openings corresponding to a pitch of the helical elements;
  • FIG. 11H is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material each of the sections being attached to either the strut portion or the helical portion wherein a gap is provided between each of the sections of graft material;
  • FIG. 11J is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material, each of the sections being attached to either the strut portion or the helical portion wherein adjacent sections of graft material is overlapped;
  • FIG. 12A is a plan view of an alternate embodiment of a stent in an expanded state
  • FIG. 12B is a plan view of the stent of FIG. 12A in a crimped state such that the gap between helical elements is the same throughout the helical portions. Additionally, the length of the stent is the same in both the crimped and expanded state;
  • FIG. 12C is a plan view of the stent of FIG. 12A in a crimped state such that the gap between helical elements changes throughout the helical portion. Additionally, the stent is longer in the crimped state than the expanded state;
  • FIG. 13 is a plan view of an alternate embodiment of a stent in accordance with the present invention.
  • FIGS. 1A and 1B are plan views of a first embodiment of stent 10 in accordance with the present invention shown in an unexpanded state and expanded state, respectively.
  • the term “plan view” will be understood to describe an unwrapped plan view. This could be thought of as slicing open a tubular stent along a line parallel to its axis and laying it out flat. It should therefore be appreciated that, in the actual stent, the top edge of the FIG. 1A will be joined to the lower edge.
  • Stent 10 is made from a common material for self expanding stents, such as Nitinol nickel-titanium alloy (Ni/Ti), as is well known in the art.
  • Ni/Ti Nitinol nickel-titanium alloy
  • the stent is laser cut from tubing, for example, with a diameter of about 5 mm ( FIG. 1A ). It is then expanded and set to a diameter of about 8 mm ( FIG. 1B ), and for pre-deployment it would be crimped to a diameter appropriate for the application, for example about 3 mm.
  • the present invention is applicable to any type and size of stent.
  • Stent 10 is generally made up of strut portion 12 and helical portion 14 with axially aligned strut portion 12 alternating with helical portion 14 .
  • strut portion 12 is positioned at either end of stent 10 .
  • Strut portion 12 being radially expandable upon deployment.
  • Each strut portion 12 includes strut ring 16 having a pattern of wave-like strut elements 16 a that progresses circumferentially about the stent.
  • Each strut element 16 a has a width equal to the peak to peak distance around the stent and a length equal to the peak-to-peak distance along the length of the stent. It will be appreciated that strut ring 16 could be partially straightened (stretched vertically in FIG.
  • the material of which stent 10 is made is such that strut element 16 a will retain some wave-like shape in a radially expanded state.
  • the stent would be crimped and fitted into a catheter, and it would expand after the catheter is inserted into the vessel and the stent is advanced out of the catheter.
  • Each helical portion is made up of a plurality of side-by-side helical elements 18 , each of which is helically wound about an axis of stent 10 .
  • Helical portion 14 is expandable radially upon deployment and compressible, expandable and bendable in a deployed state.
  • Helical elements 18 can be connected between opposed individual wave portions of strut element 16 a of different strut portions 12 .
  • each helical element 18 makes a complete rotation about the surface of stent 10 . However, they can make a partial rotation or more than one rotation.
  • the helical portion is preferably constructed to permit repeated axial compression or expansion of about 20% (preferably between 15% and 25%) and simultaneously permit bending with a minimum bending radius of about 13 mm (preferably between 10 mm and 16 mm), all without failure.
  • helical element 18 is wound at least 90 degrees between strut elements 16 a connected to helical elements 18 .
  • helical element 18 is wound at least 360 degrees between strut elements 16 a connected to helical elements 18 .
  • FIG. 2 is a plan view of a second embodiment of stent 20 similar to stent 10 of FIG. 1 .
  • the primary differences are in the structure of strut portions 12 ′ and that there are right-handed and left-handed helical portions ( 14 R and 14 L, respectively).
  • Each strut portion 12 ′ comprises two adjacent strut rings 26 , 27 connected by short link 28 .
  • the closely opposed peaks of strut elements 26 a, 27 a are connected by short link 28 , so that each strut portion 12 ′ has a double strut ring structure.
  • twin or multiple strut ring strut portions is that they offer increased radial stiffness over the single strut ring strut portion and can stabilize the strut portions so they are less affected by axial forces.
  • a right-handed helical portion 14 R the elements 18 progress clockwise about the surface of stent 10 and, in a left-handed helical portion 14 L, they progress counterclockwise.
  • Helical elements 18 essentially float and permit relatively large displacements about and along the stent axis between the two strut ring portions at either end.
  • the diameter of the stent at each helical portion 14 R, 14 L is the same as the diameter of the stent at the strut portions 12 on either side. However, this need not be the case, as will become evident from additional embodiments discussed below.
  • a benefit of using left-handed and right-handed helical portions is that when the stent deploys the two portions rotate in opposite directions, maintaining the relative rotational positions of different axial portions of the stent.
  • FIG. 3 is another embodiment of stent 30 in accordance with the present invention. It is similar to stent 20 of FIG. 2 , except that helical portions 34 include helical element 38 which progresses bi-directionally (first counterclockwise and then clockwise) about the perimeter of stent 30 between connection locations on two different strut portions 12 ′. Helical element 38 is wound at least 90 degrees from a first strut portion 12 ′ to peak 35 and is wound 90 degrees from peak 35 to a second strut portion 12 ′ in order to maintain flexibility.
  • the one-directional helical elements 18 of FIG. 1A and 1B can allow adjacent strut portions to rotate relative to one another.
  • the bi-directional helical elements 38 limit the amount adjacent strut portions can rotate about the stent axis relative to one another but still provide axial and bending flexibility.
  • FIG. 4 is a plan view of a fourth embodiment of a stent in accordance with the present invention.
  • stent 40 has strut portions 12 ′ of FIG. 2 and the helical portions 14 L, 14 R ( FIG. 2 ) and helical portions 34 ( FIG. 3 ).
  • the advantage of this construction is that combining different types of helical elements allows a mix of properties as described herein, providing the opportunity for further optimization of overall stent performance for a given application.
  • FIG. 5 is a sectional view perpendicular to the axis of a fifth embodiment of stent 30 ′ in accordance with the present invention
  • FIG. 6 is a side outline view of the same embodiment.
  • the stent has the structure shown in FIG. 3 , except that helical portions 38 ′ have a larger diameter than strut portions 12 ′. In this construction the radial stiffness of the helical portions is increased, but to a lesser degree than the strut portions.
  • the helical portions may not have as much outward force on a vessel as the strut portions when the strut is expanded.
  • the geometry of FIG. 6 will tend to force the helical portions to expand more than the strut portions, increasing the outward force of the helical portions, which equalizes the radial stiffness.
  • Nitinol structures have a biased stiffness, such that the force required to collapse the structure back towards the collapsed state is generally greater than the force that continues to dilate the diseased vessel when the stent is in its expanded state.
  • a balloon is used to assist the expansion/dilation of the vessel.
  • the biased stiffness is enough to support the open vessel, but the outward force may not be enough to open the vessel (or it may take a longer period of time).
  • a stent with the type of geometry shown in FIG. 5 would therefore be a good expedient to use in conjunction with balloon assisted expansion, or other applications requiring additional expansive force.
  • FIG. 7A is a plan view of another embodiment of stent 40 B′ in accordance with the present invention.
  • Stent 40 B′ includes strut member 42 .
  • Strut member 42 progresses helically from one end of stent 40 B′ to the other.
  • Strut member 42 forms main body of stent 40 B′.
  • each strut element 44 a is connected to a strut in a subsequent winding of strut member 42 by helical element 46 .
  • helical element 46 of helical portion 45 progresses helically less than one full rotation of 360 degrees about stent 40 B′.
  • Helical element 46 progresses in a direction opposite of the direction of which strut member 42 progresses helically about stent 40 B′.
  • helical elements 46 are axially abutted, forming a type of spring which permits a great deal of flexibility and axial expansion, while strut member 42 provides radial strength and retains the stent in its expanded condition.
  • FIG. 7B is a plan view of another embodiment of stent 40 C′ in accordance with the present invention.
  • Stent 40 C′ is similar to stent 40 B′ and includes strut member 42 .
  • Strut member 42 progresses helically from one end of stent 40 C′ to the other.
  • Strut member 42 forms main body of stent 40 C′.
  • each strut element 44 a is connected to a strut in a subsequent winding of strut member 42 by helical element 47 .
  • helical element 47 progresses helically about stent 40 C′ in the same direction as strut member 42 progresses helically about stent 40 C′.
  • Stent 40 C′ includes transitional helical portions 49 and strut portions 48 at either end of stent 40 C′ to allow strut portion 48 to be provided at either end of stent 40 C′.
  • Strut portion 48 is wound about an axis of stent 40 C.
  • Strut portion 48 has acute angle A 2 formed between a plane perpendicular to the axis of stent 40 C and a winding of strut portion 48 that is smaller than acute angle A 1 formed between the plane perpendicular to the axis of stent 40 C and the winding of strut member 42 .
  • Transitional helical portion 49 interconnects about one rotational winding or less of strut portion 48 .
  • Strut portion 48 is wound about an axis of stent 40 C′ having a number of windings less than about 1 ⁇ 4 of the total number of windings of strut member 42 .
  • the number of helical elements strut elements 50 in one rotation of a winding of strut portion 48 is greater than the number of strut elements 44 a in one rotation of strut member 42 .
  • Stents 40 B′ and 40 C′ have the advantage that the flexible helical elements are distributed more continuously along the length of the stent and may provide more continuous flexibility.
  • stent 40 B′ or 40 C′ various modifications to stent 40 B′ or 40 C′ are possible, depending upon the requirements of a particular design. For example, it might be desirable to connect fewer than all of strut elements 44 a in a particular winding to a subsequent winding, reducing the number of helical elements 46 .
  • Helical elements 46 can extend for less or for any integer or non-integer multiple of a rotation.
  • a stent could also be made of a plurality of tubular sections each having the construction of stent 40 B′ or 40 C′ and joined lengthwise by another type of section.
  • FIG. 8 is a sectional view perpendicular to the axis of an embodiment of stent 20 ′ in accordance with the present invention
  • FIG. 9 is a side outline view of the same embodiment.
  • the stent has the structure shown in FIG. 1A , except that helical portions 14 ′ neck down to a smaller diameter than strut portions 12 ′. In this construction the helical portions will exert less force on the vessel wall than if the helical portions were the same diameter. Reducing the force the stent exerts on a vessel wall can reduce the amount of damage done to a vessel and provide a better performing stent.
  • FIGS. 10A-10C are sectional views perpendicular to the axis of the stent in accordance with the present invention.
  • Stent graft 60 , 70 and 80 have a stent structure of the present invention of any of the embodiments described above with helical portions interposed between strut portions.
  • biocompatible graft material 62 covers outside 64 of stent graft 60 , as shown in FIG. 10A .
  • bio compatible graft material 62 covers inside 74 of stent 70 , as shown in FIG. 10B .
  • graft material 62 covers outside 64 and inside 74 of stent 80 , as shown in FIG. 10C .
  • Graft material 62 can be formed of any number of polymers or other biocompatible materials that have been woven or formed into a sheet or knitted surface. Alternatively, the stent can be coated with a polymer and/or drug eluting material as are known in the art.
  • FIGS. 11A-11J are side profile views of stent grafts including the features of the flexible stent structure of the present invention.
  • Stent graft 100 comprises a continuous covering of graft material 102 covering stent 10 , as shown in FIG. 11A .
  • Graft material 102 is attached to strut portions 12 .
  • Graft material 102 covers and is not attached to helical portions 14 .
  • Stent graft 110 comprises a plurality of sections 111 of graft material 112 covering the stent structure, as shown in FIG. 11B .
  • Graft material 112 is attached to strut portions 12 .
  • Graft material 112 covers at least a portion of helical portions 14 and is not attached to helical portions 14 .
  • Gap 115 is positioned between adjacent sections 111 of graft material 112 . Gap 115 will typically range in size between 0 (meaning no gap) and about 20% of the length of helical portion 14 .
  • Stent graft 120 comprises a plurality of sections 121 of graft material 122 covering the stent structure, as shown in FIG. 11C .
  • Graft material 122 is attached to strut portions 12 .
  • Graft material 122 covers and is not attached to helical portions 14 .
  • Sections 121 of graft material 122 are positioned such that there is an overlap 125 between adjacent sections 121 of graft material 122 .
  • Overlap 125 will typically range in size between 0 (meaning no gap) and about 40% of the length of helical portion 14 .
  • Stent graft 130 comprises a continuous covering of graft material 132 , as shown in FIG. 11D .
  • Graft material 132 is attached to strut portions 12 .
  • Graft material 132 covers and is not attached to helical portions 14 .
  • Graft material 132 has bulge 133 at helical portions 14 .
  • Stent graft 140 comprises a continuous covering of graft material 142 , as shown in FIG. 11E .
  • Graft material 142 has a plurality of longitudinal openings 144 over helical portions 14 .
  • Stent graft 150 comprises a continuous covering of graft material 152 , as shown in FIG. 11F .
  • Graft material 152 has bulge 153 at helical portions 14 and has a plurality of longitudinal openings 154 over helical portions 14 .
  • Stent graft 160 comprises a continuous covering of graft material 162 , as shown in FIG. 11F .
  • Graft material 162 has helical openings 164 in helical portions 14 that correspond to the pitch and angle of helical portions 14 .
  • Stent graft 170 comprises a plurality of sections 171 of graft material 172 covering stent 10 , as shown in FIG. 11H .
  • Sections 171 can be attached to strut portions 12 or helical portions 14 .
  • Gap 175 is positioned between adjacent sections 171 of graft material 172 .
  • Gap 175 will typically range in size between 0 (meaning no gap) and about 20% of the length of helical portion 14 .
  • Stent graft 180 comprises a plurality of sections 181 of graft material 182 covering stent 10 , as shown in FIG. 11J .
  • Sections 181 can be attached to strut portions 12 or helical portions 14 .
  • Sections 181 of graft material 182 are positioned such that there is an overlap 185 between adjacent sections 181 of graft material 182 .
  • Overlap 185 will typically range in size between 0 (meaning no gap) and about 40% of the length of helical portion 14 .
  • FIGS. 12A , 12 B and 12 C are plan views of stent 200 in accordance with the present invention.
  • FIG. 12A shows stent 200 in an expanded state with gap 202 between helical elements 18 .
  • FIGS. 12B and 12C show stent 200 in two different compressed states.
  • stent 200 is compressed such that gap 212 between side-by-side helical elements 18 is about the same throughout helical portion 14 .
  • the size of gap 212 between side-by-side helical elements 18 can range between 0 and about the size of the gap 202 in the expanded state, for example, as shown in FIG. 12A . In other words, when the size of the gap is 0, there is no space between side-by-side helical elements 18 and side-by-side helical elements 18 contact one another.
  • the helical elements of the stent shown in FIG. 12B have been wrapped around the stent a number of times such that in the crimped state the overall length 211 of the stent in the crimped state is the same as the overall length 201 of the stent in the expanded state shown in FIG. 12A , thereby eliminating foreshortening.
  • the spacing between windings of strut member 42 in the compressed state is substantially the same to the spacing between windings of strut member 12 in the deployed state.
  • stent 200 is compressed such that helical element 18 is elongated and gap 222 between side-by-side helical elements 18 varies throughout the axial length of helical portion 14 .
  • the size of gap 222 between adjacent helical elements 18 can range between 0 and about the size of the gap 202 in the expanded state, for example, as shown in FIG. 12A . In other words, when the size of the gap is 0, there is no space between side-by-side helical elements 18 and side-by-side helical elements 18 contact one another.
  • Helical elements 18 are elongated elements without overlapping in the radial direction. In the deployed state, helical elements 18 are substantially parallel.
  • Strut member 12 and helical elements 18 define a cylinder having a constant diameter.
  • the overall length 221 of the stent in the crimped state is greater then the overall length 201 of the stent in the expanded state.
  • helical elements 18 are elongated elements in both the compressed and deployed state wherein the distance between at least some adjacent helical elements in the compressed state varies along the length of the adjacent helical elements and is in a range from zero and about the maximum distance between adjacent helical elements in the deployed state.
  • the spacing between windings of strut member 42 in the compressed state is greater than the spacing between windings of strut member 12 in the deployed state.
  • Stent 200 in the compressed state as shown in FIG.
  • the minimum angle of helical elements 18 with the longitudinal axis of stent 200 in the compressed state is less than the minimum angle of helical elements 18 with the longitudinal axis of stent 200 in the deployed state.
  • An additional method can be provided to crimp the stent such that the length of helical portions is shorter in the crimped state than in the expanded state. For example, if the stent of FIG. 12A were crimped similar to that shown in FIG. 12B , except no gap exists between side-by-side helical elements the stent would be have length 211 in the crimped state which is shorter than length 201 in the expanded state.
  • a method of crimping provides a stent where the overall length is the same in the crimped and expanded state and there is no gap between helical elements in the crimped state.
  • one preferred embodiment of the stent is to permit repeated axial compression or expansion of about 20% and simultaneously permit bending with a minimum bending radius of about 13 mm.
  • One method to construct a stent of the present invention with a specific target for flexibility is to vary the ratio between the sum of the gap space in the helical portion to the overall length. By increasing that ratio, the flexibility of the stent increases. This ratio will also be approximately the maximum axial compression the stent will allow. It will be appreciated that the maximum axial compression for safety may be limited by other factors such as strain in the helical elements.
  • FIG. 13 is a plan view of a stent 300 in accordance with the present invention.
  • Stent 300 is similar to other embodiments described above except it includes various configurations and various axial lengths of strut portions and various configurations and various axial lengths of helical portions.
  • Strut portions 302 positioned at the outer most portion of stent 300 includes long strut elements 301 .
  • Long strut elements 301 have length 311 .
  • Length 311 of long strut element 301 is greater than length 312 of strut portions 304 positioned at the inner portion of stent 300 .
  • Long strut elements 301 provided on the ends of the stent may be advantageous to provide better anchoring and provide an area for adjacent stents to overlap, but not impede the flexibility of the helical portion.
  • the length of diseased artery may be long, often longer than 10 cm. Multiple stents may be required to treat these long sections of diseased arteries.
  • a common procedure in this case is to overlap the adjacent stents so that the vessel being treated is covered.
  • An advantage of the present invention is that the elements that allow bending and axial flexibility (helical portion) are different than the elements that provide radial structure (strut portion) so that the strut portions on adjacent stents may overlap and not impede the movement of the helical portion and therefore the overall flexibility of the stent.
  • Helical portion 303 that is adjacent to the strut portion 302 comprises helical elements 18 that are connected to every strut element 301 of strut portion 302 .
  • Helical portion 303 can provide a high percentage of surface area for optimized delivery of a drug or other therapeutic agent.
  • Strut portion 304 is connected to helical portion 303 by helical element 18 at every strut element 16 a on side 320 of strut portion 304 and is connected to helical portion 309 at every other strut element 16 a on side 321 of strut portion 304 .
  • Helical portion 309 provides a lower percentage of surface area and greater flexibility than helical portion 303 . This type of configuration can provide a transition from a stiffer helical portion that has a high percentage of surface area to a more flexible helical portion.
  • Helical portion 309 has a higher ratio of the sum of gap lengths 323 to length 324 of helical portion 309 than the sum of gap lengths 325 to length 326 of helical portion 303 , so that helical portion 309 will generally have greater flexibility.
  • Strut portion 306 has half as many strut elements 305 as strut portions 302 or 304 and therefore generally has more open area compared to strut portion 302 or strut portion 304 .
  • An advantage of a stent including a portion having a larger open area than other portions of the stent is that the larger open portion of the stent can be placed over an arterial bifurcation and not impede blood flow. Whereas the strut portion with a higher strut element density may impede blood flow.
  • the stent structure of the present invention namely flexible helical portions flanked on either side by strut portions, provide an optimized structure where the strut portions stabilize a naturally unstable helical structure, and the helical portions provide net flexibility. There is substantial design optimization potential in combining various embodiments of the two portions.
  • the flexible stents and stent grafts of the present invention may be placed within vessels using procedures well known in the art.
  • the flexible stents and stent grafts may be loaded into the proximal end of a catheter and advanced through the catheter and released at the desired site.
  • the flexible stents and stent grafts may be carried about the distal end of the catheter in a compressed state and released at the desired site.
  • the flexible stents or stent grafts may either be self-expanding or expanded by means such as an inflatable balloon segment of the catheter. After the stent(s) or stent graft(s) have been deposited at the desired intralumenal site, the catheter is withdrawn.
  • the flexible stents and stent grafts of the present invention may be placed within body lumen such as vascular vessels or ducts of any mammal species including humans, without damaging the lumenal wall.
  • the flexible stent can be placed within a lesion or an aneurysm for treating the aneurysm.
  • the flexible stent is placed in a super femoral artery upon insertion into the vessel, the flexible stent or stent grafts provides coverage of at least about 50% of the vessel.
  • a stent could be made with only right-handed or only left-handed helical portions, or the helical portions could have multiple reversals in winding direction rather than just one.
  • the helical portions could have any number of turns per unit length or a variable pitch, and the strut rings and/or helical portions could be of unequal length along the stent.

Abstract

A flexible stent structure includes a plurality of axially spaced strut portions defining generally tubular axial segments of the stent and constructed to be radially expandable. A helical portion is interposed axially between two strut portions and has a plurality of helical elements connected between circumferentially spaced locations on the two strut portions. The helical elements extend helically between those locations and the length of a helical element is sufficient so that, when the stent is in a radially expanded state, it can simultaneously withstand repeated axial compression or expansion and bending.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • This application is a divisional of U.S. patent application Ser. No. 11/397,987, filed Apr. 4, 2006, which is a continuation-in-part of U.S. patent application Ser. No. 11/250,226 filed Oct. 14, 2005, now abandoned, which claims the benefit of U.S. Provisional patent application No. 60/667,613 filed Apr. 4, 2005, the entirety of all of which are hereby incorporated by reference into this application.
  • BACKGROUND OF THE INVENTION
  • The present invention relates generally to expandable tubular structures capable of insertion into small spaces in living bodies and, more particularly, concerns a stent structure which is capable of substantial and repeated flexing at points along its length without mechanical failures and with no substantial changes in its geometry.
  • A stent is a tubular structure that, in a radially compressed or crimped state, may be inserted into a confined space in a living body, such as an artery or other vessel. After insertion, the stent may be expanded radially to enlarge the space in which it is located. Stents are typically characterized as balloon-expanding (BX) or self-expanding (SX). A balloon-expanding stent requires a balloon, which is usually part of a delivery system, to expand the stent from within and to dilate the vessel. A self expanding stent is designed, through choice of material, geometry, or manufacturing techniques, to expand from the crimped state to an expanded state once it is released into the intended vessel. In certain situations higher forces than the expanding force of the self expanding stent are required to dilate a diseased vessel. In this case, a balloon or similar device might be employed to aid the expansion of a self expanding stent.
  • Stents are typically used in the treatment of vascular and non-vascular diseases. For instance, a crimped stent may be inserted into a clogged artery and then expanded to restore blood flow in the artery. Prior to release, the stent would typically be retained in its crimped state within a catheter and the like. Upon completion of the procedure, the stent is left inside the patient's artery in its expanded state. The health, and sometimes the life, of the patient depend upon the stent's ability to remain in its expanded state.
  • Many available stents are flexible in their crimped state in order to facilitate the delivery of the stent, for example within an artery. Few are flexible after being deployed and expanded. Yet, after deployment, in certain applications, a stent may be subjected to substantial flexing or bending, axial compressions and repeated displacements at points along its length, for example, when stenting the superficial femoral artery. This can produce severe strain and fatigue, resulting in failure of the stent.
  • A similar problem exists with respect to stent-like structures. An example would be a stent-like structure used with other components in a catheter-based valve delivery system. Such a stent-like structure holds a valve which is placed in a vessel.
  • SUMMARY OF THE INVENTION
  • In accordance with the present invention, a stent or a stent-like structure is constructed to have different types of tubular portions along its length. In general, there are strut portions and helical portions, where the strut portions are constructed primarily to provide radial expansion and radial strength, and the helical portions are constructed primarily to permit repeated flexing and axial compression and expansion. The flexing and axial compression are likely to be required simultaneously, so the stent structure permits repeated and substantial flexing while in an axially compressed or expanded state, and it permits axial compression while in a flexed state. Preferably, strut portions are provided between helical portions or helical portions are provided between strut portions. In a preferred embodiment, the stent is self-expanding and strut portions and helical portions alternate along the length of the stent.
  • The stent is preferably constructed so that, in the expanded state the helical portions permit axial compression or expansion of about 20% (preferably between 15% and 25%) and simultaneously permit bending with a minimum bending radius of about 13 mm (preferably between 10 mm and 16 mm).
  • In accordance with another aspect of the invention, a helical portion is made of helical elements which extend helically about the axis of the stent between points on two different strut portions which are spaced apart circumferentially by a distance which is more than approximately 25% of the circumference of the stent (which is equivalent to an extent of 90 degrees about the axis of the stent) when it is in its expanded state.
  • In accordance with yet another aspect of the invention, a helical portion is made of helical elements which extend helically about the axis of the stent between locations on two different strut portions. In one embodiment a helical element is bi-directional, in that it extends first in one circumferential direction and then the other between the two locations and has a peak.
  • In accordance with yet another aspect of the invention, a stent has a plurality of axially spaced strut portions defining generally tubular axial segments of the stent and constructed to be radially expandable. A helical portion is interposed axially between two strut portions, and the helical portion has a plurality of helical elements connected between circumferentially spaced locations on two strut portions. A helical element extends helically between these locations, and at least part of the helical portion has a greater diameter than a strut portion when the stent is in an expanded state. In an alternate embodiment, at least part of the helical portion has a smaller diameter than the strut portion when the strut is in an expanded state.
  • In one embodiment, the helical element is wound at least 90 degrees between strut elements connected to the helical element. In another embodiment, the helical element is wound at least 360 degrees between strut elements connected to the helical element.
  • In an alternate embodiment, stent grafts are formed of a biocompatible graft material covering the outside, inside or both the outside and inside of the stent. The stent graft can have any embodiment of a stent structure of the present invention. Stent graft devices are used, for example, in the treatment of aneurysms, dissections and tracheo-bronchial strictures. The stent can also be coated with a polymer and/or drug eluting material as are known in the art.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The foregoing description, as well as further objects, features, and advantages of the present invention will be understood more completely from the following detailed description of presently preferred, but nonetheless illustrative embodiments in accordance with the present invention, with reference being had to the accompanying drawings, in which:
  • FIG. 1A is a plan view of a first embodiment of a stent in accordance with the present invention, the stent being shown in an unexpanded state;
  • FIG. 1B is a plan view of the first embodiment of a stent in accordance with the present invention, the stent being shown in a radially expanded state;
  • FIG. 2 is a plan view of a second embodiment of a stent in accordance with the present invention;
  • FIG. 3 is a plan view of a third embodiment of a stent in accordance with the present invention;
  • FIG. 4 is a plan view of a fourth embodiment of a stent in accordance with the present invention;
  • FIG. 5 is a sectional end view of a fifth embodiment of a stent in accordance with the present invention;
  • FIG. 6 is a lengthwise side outline view of the same embodiment as FIG. 5;
  • FIG. 7A is a plan view of another embodiment of a stent in accordance with the present invention;
  • FIG. 7B is a plan view of another embodiment of the stent in accordance with the present invention;
  • FIG. 8 is a sectional end view of another embodiment of the stent in accordance with the present invention;
  • FIG. 9 is a lengthwise side outline view of the embodiment shown in FIG. 8;
  • FIG. 10A is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an outer surface of the stent;
  • FIG. 10B is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an inner surface of the stent;
  • FIG. 10C is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an outer surface and an inner surface of the stent;
  • FIG. 11A is a side view of an alternate embodiment of a stent in accordance with the present invention including graft material attached to the strut portion, the graft material covering the strut portion and the helical portion;
  • FIG. 11B is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material wherein a gap is provided between each of the sections of graft material;
  • FIG. 11C is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of a biocompatible graft material wherein the graft material of adjacent sections is overlapped;
  • FIG. 11D is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material, the graft material having a bulge at the helical portions;
  • FIG. 11E is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material, the graft material having a plurality of longitudinal openings over the helical portions;
  • FIG. 11F is a side view of an alternate embodiment of a stent in accordance with the present invention the graft material having a bulge at the helical portions and the graft material having a plurality of longitudinal openings over the helical portions;
  • FIG. 11G is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material having a plurality of helical openings corresponding to a pitch of the helical elements;
  • FIG. 11H is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material each of the sections being attached to either the strut portion or the helical portion wherein a gap is provided between each of the sections of graft material;
  • FIG. 11J is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material, each of the sections being attached to either the strut portion or the helical portion wherein adjacent sections of graft material is overlapped;
  • FIG. 12A is a plan view of an alternate embodiment of a stent in an expanded state;
  • FIG. 12B is a plan view of the stent of FIG. 12A in a crimped state such that the gap between helical elements is the same throughout the helical portions. Additionally, the length of the stent is the same in both the crimped and expanded state;
  • FIG. 12C is a plan view of the stent of FIG. 12A in a crimped state such that the gap between helical elements changes throughout the helical portion. Additionally, the stent is longer in the crimped state than the expanded state; and
  • FIG. 13 is a plan view of an alternate embodiment of a stent in accordance with the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Reference will now be made in greater detail to a preferred embodiment of the invention, an example of which is illustrated in the accompanying drawings. Wherever possible, the same reference numerals will be used throughout the drawings and the description to refer to the same or like parts.
  • FIGS. 1A and 1B are plan views of a first embodiment of stent 10 in accordance with the present invention shown in an unexpanded state and expanded state, respectively. As used herein, the term “plan view” will be understood to describe an unwrapped plan view. This could be thought of as slicing open a tubular stent along a line parallel to its axis and laying it out flat. It should therefore be appreciated that, in the actual stent, the top edge of the FIG. 1A will be joined to the lower edge.
  • Stent 10 is made from a common material for self expanding stents, such as Nitinol nickel-titanium alloy (Ni/Ti), as is well known in the art. Typically, the stent is laser cut from tubing, for example, with a diameter of about 5 mm (FIG. 1A). It is then expanded and set to a diameter of about 8 mm (FIG. 1B), and for pre-deployment it would be crimped to a diameter appropriate for the application, for example about 3 mm. However, it is contemplated that the present invention is applicable to any type and size of stent.
  • Stent 10 is generally made up of strut portion 12 and helical portion 14 with axially aligned strut portion 12 alternating with helical portion 14. In a preferred embodiment, strut portion 12 is positioned at either end of stent 10. Strut portion 12 being radially expandable upon deployment. Each strut portion 12 includes strut ring 16 having a pattern of wave-like strut elements 16 a that progresses circumferentially about the stent. Each strut element 16 a has a width equal to the peak to peak distance around the stent and a length equal to the peak-to-peak distance along the length of the stent. It will be appreciated that strut ring 16 could be partially straightened (stretched vertically in FIG. 1B) so as to widen strut elements 16 a and reduce their length. This is equivalent to expanding stent 10 radially. Preferably, the material of which stent 10 is made is such that strut element 16 a will retain some wave-like shape in a radially expanded state. For delivery, the stent would be crimped and fitted into a catheter, and it would expand after the catheter is inserted into the vessel and the stent is advanced out of the catheter.
  • Each helical portion is made up of a plurality of side-by-side helical elements 18, each of which is helically wound about an axis of stent 10. Helical portion 14 is expandable radially upon deployment and compressible, expandable and bendable in a deployed state. Helical elements 18 can be connected between opposed individual wave portions of strut element 16 a of different strut portions 12. In this embodiment, each helical element 18 makes a complete rotation about the surface of stent 10. However, they can make a partial rotation or more than one rotation. The helical portion is preferably constructed to permit repeated axial compression or expansion of about 20% (preferably between 15% and 25%) and simultaneously permit bending with a minimum bending radius of about 13 mm (preferably between 10 mm and 16 mm), all without failure.
  • Improved flexibility and axial compression can generally be accomplished if helical element 18 is wound at least 90 degrees between strut elements 16 a connected to helical elements 18. Alternatively, helical element 18 is wound at least 360 degrees between strut elements 16 a connected to helical elements 18.
  • FIG. 2 is a plan view of a second embodiment of stent 20 similar to stent 10 of FIG. 1. The primary differences are in the structure of strut portions 12′ and that there are right-handed and left-handed helical portions (14R and 14L, respectively). Each strut portion 12′ comprises two adjacent strut rings 26, 27 connected by short link 28. The closely opposed peaks of strut elements 26 a, 27 a are connected by short link 28, so that each strut portion 12′ has a double strut ring structure. It would also be possible to connect multiple strut rings together to form a larger strut portion. The advantage of twin or multiple strut ring strut portions is that they offer increased radial stiffness over the single strut ring strut portion and can stabilize the strut portions so they are less affected by axial forces.
  • In a right-handed helical portion 14R, the elements 18 progress clockwise about the surface of stent 10 and, in a left-handed helical portion 14L, they progress counterclockwise. Helical elements 18 essentially float and permit relatively large displacements about and along the stent axis between the two strut ring portions at either end. In this embodiment, it will be appreciated that the diameter of the stent at each helical portion 14R, 14L is the same as the diameter of the stent at the strut portions 12 on either side. However, this need not be the case, as will become evident from additional embodiments discussed below. A benefit of using left-handed and right-handed helical portions is that when the stent deploys the two portions rotate in opposite directions, maintaining the relative rotational positions of different axial portions of the stent.
  • FIG. 3 is another embodiment of stent 30 in accordance with the present invention. It is similar to stent 20 of FIG. 2, except that helical portions 34 include helical element 38 which progresses bi-directionally (first counterclockwise and then clockwise) about the perimeter of stent 30 between connection locations on two different strut portions 12′. Helical element 38 is wound at least 90 degrees from a first strut portion 12′ to peak 35 and is wound 90 degrees from peak 35 to a second strut portion 12′ in order to maintain flexibility. The one-directional helical elements 18 of FIG. 1A and 1B can allow adjacent strut portions to rotate relative to one another. The bi-directional helical elements 38 limit the amount adjacent strut portions can rotate about the stent axis relative to one another but still provide axial and bending flexibility.
  • FIG. 4 is a plan view of a fourth embodiment of a stent in accordance with the present invention. In this case, stent 40 has strut portions 12′ of FIG. 2 and the helical portions 14L, 14R (FIG. 2) and helical portions 34 (FIG. 3). The advantage of this construction is that combining different types of helical elements allows a mix of properties as described herein, providing the opportunity for further optimization of overall stent performance for a given application.
  • FIG. 5 is a sectional view perpendicular to the axis of a fifth embodiment of stent 30′ in accordance with the present invention, and FIG. 6 is a side outline view of the same embodiment. The stent has the structure shown in FIG. 3, except that helical portions 38′ have a larger diameter than strut portions 12′. In this construction the radial stiffness of the helical portions is increased, but to a lesser degree than the strut portions.
  • When all portions of the stent have the same diameter, the helical portions may not have as much outward force on a vessel as the strut portions when the strut is expanded. The geometry of FIG. 6 will tend to force the helical portions to expand more than the strut portions, increasing the outward force of the helical portions, which equalizes the radial stiffness.
  • Nitinol structures have a biased stiffness, such that the force required to collapse the structure back towards the collapsed state is generally greater than the force that continues to dilate the diseased vessel when the stent is in its expanded state. With some self expanding Nitinol stents, a balloon is used to assist the expansion/dilation of the vessel. The biased stiffness is enough to support the open vessel, but the outward force may not be enough to open the vessel (or it may take a longer period of time). A stent with the type of geometry shown in FIG. 5 would therefore be a good expedient to use in conjunction with balloon assisted expansion, or other applications requiring additional expansive force.
  • FIG. 7A is a plan view of another embodiment of stent 40B′ in accordance with the present invention. Stent 40B′ includes strut member 42. Strut member 42 progresses helically from one end of stent 40B′ to the other. Strut member 42 forms main body of stent 40B′. In this embodiment, each strut element 44 a is connected to a strut in a subsequent winding of strut member 42 by helical element 46. In this embodiment, helical element 46 of helical portion 45 progresses helically less than one full rotation of 360 degrees about stent 40B′. Helical element 46 progresses in a direction opposite of the direction of which strut member 42 progresses helically about stent 40B′.
  • Preferably, helical elements 46 are axially abutted, forming a type of spring which permits a great deal of flexibility and axial expansion, while strut member 42 provides radial strength and retains the stent in its expanded condition.
  • FIG. 7B is a plan view of another embodiment of stent 40C′ in accordance with the present invention. Stent 40C′ is similar to stent 40B′ and includes strut member 42. Strut member 42 progresses helically from one end of stent 40C′ to the other. Strut member 42 forms main body of stent 40C′. In the present embodiment, each strut element 44 a is connected to a strut in a subsequent winding of strut member 42 by helical element 47. In this embodiment, helical element 47 progresses helically about stent 40C′ in the same direction as strut member 42 progresses helically about stent 40C′. Stent 40C′ includes transitional helical portions 49 and strut portions 48 at either end of stent 40C′ to allow strut portion 48 to be provided at either end of stent 40C′. Strut portion 48 is wound about an axis of stent 40C. Strut portion 48 has acute angle A2 formed between a plane perpendicular to the axis of stent 40C and a winding of strut portion 48 that is smaller than acute angle A1 formed between the plane perpendicular to the axis of stent 40C and the winding of strut member 42. Transitional helical portion 49 interconnects about one rotational winding or less of strut portion 48. Strut portion 48 is wound about an axis of stent 40C′ having a number of windings less than about ¼ of the total number of windings of strut member 42. The number of helical elements strut elements 50 in one rotation of a winding of strut portion 48 is greater than the number of strut elements 44 a in one rotation of strut member 42.
  • Stents 40B′ and 40C′ have the advantage that the flexible helical elements are distributed more continuously along the length of the stent and may provide more continuous flexibility. Those skilled in the art will appreciate that various modifications to stent 40B′ or 40C′ are possible, depending upon the requirements of a particular design. For example, it might be desirable to connect fewer than all of strut elements 44 a in a particular winding to a subsequent winding, reducing the number of helical elements 46. Helical elements 46 can extend for less or for any integer or non-integer multiple of a rotation. A stent could also be made of a plurality of tubular sections each having the construction of stent 40B′ or 40C′ and joined lengthwise by another type of section.
  • FIG. 8 is a sectional view perpendicular to the axis of an embodiment of stent 20′ in accordance with the present invention, and FIG. 9 is a side outline view of the same embodiment. The stent has the structure shown in FIG. 1A, except that helical portions 14′ neck down to a smaller diameter than strut portions 12′. In this construction the helical portions will exert less force on the vessel wall than if the helical portions were the same diameter. Reducing the force the stent exerts on a vessel wall can reduce the amount of damage done to a vessel and provide a better performing stent.
  • FIGS. 10A-10C are sectional views perpendicular to the axis of the stent in accordance with the present invention. Stent graft 60, 70 and 80 have a stent structure of the present invention of any of the embodiments described above with helical portions interposed between strut portions. In one embodiment, biocompatible graft material 62 covers outside 64 of stent graft 60, as shown in FIG. 10A. Alternatively, bio compatible graft material 62 covers inside 74 of stent 70, as shown in FIG. 10B. Alternatively, graft material 62 covers outside 64 and inside 74 of stent 80, as shown in FIG. 10C. Graft material 62 can be formed of any number of polymers or other biocompatible materials that have been woven or formed into a sheet or knitted surface. Alternatively, the stent can be coated with a polymer and/or drug eluting material as are known in the art.
  • FIGS. 11A-11J are side profile views of stent grafts including the features of the flexible stent structure of the present invention.
  • Stent graft 100 comprises a continuous covering of graft material 102 covering stent 10, as shown in FIG. 11A. Graft material 102 is attached to strut portions 12. Graft material 102 covers and is not attached to helical portions 14.
  • Stent graft 110 comprises a plurality of sections 111 of graft material 112 covering the stent structure, as shown in FIG. 11B. Graft material 112 is attached to strut portions 12. Graft material 112 covers at least a portion of helical portions 14 and is not attached to helical portions 14. Gap 115 is positioned between adjacent sections 111 of graft material 112. Gap 115 will typically range in size between 0 (meaning no gap) and about 20% of the length of helical portion 14.
  • Stent graft 120 comprises a plurality of sections 121 of graft material 122 covering the stent structure, as shown in FIG. 11C. Graft material 122 is attached to strut portions 12. Graft material 122 covers and is not attached to helical portions 14. Sections 121 of graft material 122 are positioned such that there is an overlap 125 between adjacent sections 121 of graft material 122. Overlap 125 will typically range in size between 0 (meaning no gap) and about 40% of the length of helical portion 14.
  • Stent graft 130 comprises a continuous covering of graft material 132, as shown in FIG. 11D. Graft material 132 is attached to strut portions 12. Graft material 132 covers and is not attached to helical portions 14. Graft material 132 has bulge 133 at helical portions 14.
  • Stent graft 140 comprises a continuous covering of graft material 142, as shown in FIG. 11E. Graft material 142 has a plurality of longitudinal openings 144 over helical portions 14.
  • Stent graft 150 comprises a continuous covering of graft material 152, as shown in FIG. 11F. Graft material 152 has bulge 153 at helical portions 14 and has a plurality of longitudinal openings 154 over helical portions 14.
  • Stent graft 160 comprises a continuous covering of graft material 162, as shown in FIG. 11F. Graft material 162 has helical openings 164 in helical portions 14 that correspond to the pitch and angle of helical portions 14.
  • Stent graft 170 comprises a plurality of sections 171 of graft material 172 covering stent 10, as shown in FIG. 11H. Sections 171 can be attached to strut portions 12 or helical portions 14. Gap 175 is positioned between adjacent sections 171 of graft material 172. Gap 175 will typically range in size between 0 (meaning no gap) and about 20% of the length of helical portion 14.
  • Stent graft 180 comprises a plurality of sections 181 of graft material 182 covering stent 10, as shown in FIG. 11J. Sections 181 can be attached to strut portions 12 or helical portions 14. Sections 181 of graft material 182 are positioned such that there is an overlap 185 between adjacent sections 181 of graft material 182. Overlap 185 will typically range in size between 0 (meaning no gap) and about 40% of the length of helical portion 14.
  • FIGS. 12A, 12B and 12C are plan views of stent 200 in accordance with the present invention. FIG. 12A shows stent 200 in an expanded state with gap 202 between helical elements 18. FIGS. 12B and 12C show stent 200 in two different compressed states. In FIG. 12B stent 200 is compressed such that gap 212 between side-by-side helical elements 18 is about the same throughout helical portion 14. The size of gap 212 between side-by-side helical elements 18 can range between 0 and about the size of the gap 202 in the expanded state, for example, as shown in FIG. 12A. In other words, when the size of the gap is 0, there is no space between side-by-side helical elements 18 and side-by-side helical elements 18 contact one another.
  • The helical elements of the stent shown in FIG. 12B have been wrapped around the stent a number of times such that in the crimped state the overall length 211 of the stent in the crimped state is the same as the overall length 201 of the stent in the expanded state shown in FIG. 12A, thereby eliminating foreshortening. The spacing between windings of strut member 42 in the compressed state is substantially the same to the spacing between windings of strut member 12 in the deployed state.
  • In FIG. 12C stent 200 is compressed such that helical element 18 is elongated and gap 222 between side-by-side helical elements 18 varies throughout the axial length of helical portion 14. The size of gap 222 between adjacent helical elements 18 can range between 0 and about the size of the gap 202 in the expanded state, for example, as shown in FIG. 12A. In other words, when the size of the gap is 0, there is no space between side-by-side helical elements 18 and side-by-side helical elements 18 contact one another. Helical elements 18 are elongated elements without overlapping in the radial direction. In the deployed state, helical elements 18 are substantially parallel. Strut member 12 and helical elements 18 define a cylinder having a constant diameter. In FIG. 12C, the overall length 221 of the stent in the crimped state is greater then the overall length 201 of the stent in the expanded state. In other words, helical elements 18 are elongated elements in both the compressed and deployed state wherein the distance between at least some adjacent helical elements in the compressed state varies along the length of the adjacent helical elements and is in a range from zero and about the maximum distance between adjacent helical elements in the deployed state. The spacing between windings of strut member 42 in the compressed state is greater than the spacing between windings of strut member 12 in the deployed state. Stent 200 in the compressed state, as shown in FIG. 12C, is longer than in the deployed state, as shown in FIG. 12A. The minimum angle of helical elements 18 with the longitudinal axis of stent 200 in the compressed state is less than the minimum angle of helical elements 18 with the longitudinal axis of stent 200 in the deployed state.
  • An additional method can be provided to crimp the stent such that the length of helical portions is shorter in the crimped state than in the expanded state. For example, if the stent of FIG. 12A were crimped similar to that shown in FIG. 12B, except no gap exists between side-by-side helical elements the stent would be have length 211 in the crimped state which is shorter than length 201 in the expanded state. In one embodiment, a method of crimping provides a stent where the overall length is the same in the crimped and expanded state and there is no gap between helical elements in the crimped state.
  • As described above, one preferred embodiment of the stent is to permit repeated axial compression or expansion of about 20% and simultaneously permit bending with a minimum bending radius of about 13 mm. One method to construct a stent of the present invention with a specific target for flexibility is to vary the ratio between the sum of the gap space in the helical portion to the overall length. By increasing that ratio, the flexibility of the stent increases. This ratio will also be approximately the maximum axial compression the stent will allow. It will be appreciated that the maximum axial compression for safety may be limited by other factors such as strain in the helical elements.
  • FIG. 13 is a plan view of a stent 300 in accordance with the present invention. Stent 300 is similar to other embodiments described above except it includes various configurations and various axial lengths of strut portions and various configurations and various axial lengths of helical portions. Strut portions 302 positioned at the outer most portion of stent 300 includes long strut elements 301. Long strut elements 301 have length 311. Length 311 of long strut element 301 is greater than length 312 of strut portions 304 positioned at the inner portion of stent 300. Long strut elements 301 provided on the ends of the stent may be advantageous to provide better anchoring and provide an area for adjacent stents to overlap, but not impede the flexibility of the helical portion. In some vasculatures, notably the femoropopliteal arteries, the length of diseased artery may be long, often longer than 10 cm. Multiple stents may be required to treat these long sections of diseased arteries. A common procedure in this case is to overlap the adjacent stents so that the vessel being treated is covered. When some conventional stents are overlapped in this manner, the mechanism which makes them flexible is impeded and this artificial stiffening can cause many problems, including stent fractures. An advantage of the present invention is that the elements that allow bending and axial flexibility (helical portion) are different than the elements that provide radial structure (strut portion) so that the strut portions on adjacent stents may overlap and not impede the movement of the helical portion and therefore the overall flexibility of the stent.
  • Helical portion 303 that is adjacent to the strut portion 302 comprises helical elements 18 that are connected to every strut element 301 of strut portion 302. Helical portion 303 can provide a high percentage of surface area for optimized delivery of a drug or other therapeutic agent. Strut portion 304 is connected to helical portion 303 by helical element 18 at every strut element 16 a on side 320 of strut portion 304 and is connected to helical portion 309 at every other strut element 16 a on side 321 of strut portion 304. Helical portion 309 provides a lower percentage of surface area and greater flexibility than helical portion 303. This type of configuration can provide a transition from a stiffer helical portion that has a high percentage of surface area to a more flexible helical portion.
  • Helical portion 309 has a higher ratio of the sum of gap lengths 323 to length 324 of helical portion 309 than the sum of gap lengths 325 to length 326 of helical portion 303, so that helical portion 309 will generally have greater flexibility.
  • Strut portion 306 has half as many strut elements 305 as strut portions 302 or 304 and therefore generally has more open area compared to strut portion 302 or strut portion 304. An advantage of a stent including a portion having a larger open area than other portions of the stent is that the larger open portion of the stent can be placed over an arterial bifurcation and not impede blood flow. Whereas the strut portion with a higher strut element density may impede blood flow.
  • The stent structure of the present invention, namely flexible helical portions flanked on either side by strut portions, provide an optimized structure where the strut portions stabilize a naturally unstable helical structure, and the helical portions provide net flexibility. There is substantial design optimization potential in combining various embodiments of the two portions.
  • The flexible stents and stent grafts of the present invention may be placed within vessels using procedures well known in the art. The flexible stents and stent grafts may be loaded into the proximal end of a catheter and advanced through the catheter and released at the desired site. Alternatively, the flexible stents and stent grafts may be carried about the distal end of the catheter in a compressed state and released at the desired site. The flexible stents or stent grafts may either be self-expanding or expanded by means such as an inflatable balloon segment of the catheter. After the stent(s) or stent graft(s) have been deposited at the desired intralumenal site, the catheter is withdrawn.
  • The flexible stents and stent grafts of the present invention may be placed within body lumen such as vascular vessels or ducts of any mammal species including humans, without damaging the lumenal wall. For example, the flexible stent can be placed within a lesion or an aneurysm for treating the aneurysm. In one embodiment, the flexible stent is placed in a super femoral artery upon insertion into the vessel, the flexible stent or stent grafts provides coverage of at least about 50% of the vessel.
  • Although presently preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that many additions, modifications, and substitutions are possible without departing from the scope and spirit of the invention as defined by the accompanying claims. For example, a stent could be made with only right-handed or only left-handed helical portions, or the helical portions could have multiple reversals in winding direction rather than just one. Also, the helical portions could have any number of turns per unit length or a variable pitch, and the strut rings and/or helical portions could be of unequal length along the stent.

Claims (72)

1. Flexible stent comprising:
a helical portion comprising a plurality of side-by-side, individual helical elements helically wound about an axis of said stent, said helical portion being expandable radially upon deployment and compressible, expandable and bendable in a deployed state; and a strut portion on either side of said helical portion, each of said strut portions comprising axially aligned strut elements having a first end connected to said helical elements of said helical portion, said strut portions being radially expandable upon deployment.
2. The stent of claim 1 wherein said helical elements are wound at least 90 degrees between said strut elements connected to said helical elements in said deployed state.
3. The stent of claim 1 wherein said helical elements are wound at least 360 degrees between said strut elements connected to said helical elements in said deployed state.
4. The stent of claim 1 further comprising one or more additional said helical portions and one or more additional said strut portions wherein one of said one or more additional said helical portions is connected to a second end of one of said strut portions, said one or more additional said helical portions being connected respectively to said one or more additional said strut portions such that each of said helical portions is interposed between a pair of said strut portions.
5. The stent of claim 4 wherein said helical elements of each of said helical portions are wound in the same direction.
6. The stent of claim 4 wherein said helical elements of at least one of said helical portions are wound in a direction opposite to said helical elements of another of said helical portions.
7. The stent of claim 1 wherein one or more pairs of helical portions are separated and flanked by said strut portions, said helical elements of one portion of said pair being wound in a direction opposite to said helical elements of the other portion of said pair.
8. The stent of claim 1 wherein said strut elements of said strut portion have a wave pattern of individual wave portions, each individual wave portion having a peak.
9. The stent of claim 8 wherein each of said helical elements is connected to a respective one of said peaks of said strut elements.
10. The stent of claim 8 wherein some of said helical elements are connected to some of said peaks of said strut elements.
11. The stent of claim 8 wherein every other one of said peaks of said strut elements are connected by a respective one of said helical elements.
12. The stent of claim 8 wherein said strut portion comprises a plurality of said strut elements and peaks of said individual wave members being connected to one another by a link.
13. The stent of claim 4 wherein at least one of said strut portions comprises a plurality of said strut elements, said strut elements of said strut portion have a wave pattern of individual wave portions, each individual wave portion having a peak and peaks of said individual wave members being connected to one another by a link.
14. The stent of claim 13 wherein said at least of said one strut portions is at either end of said stent.
15. The stent of claim 1 wherein said helical elements extend helically in a first direction from a first said strut element to a peak and then in an opposite direction from said peak to a second said strut element.
16. The stent of claim 1 further comprising one or more additional said helical portions and one or more additional said strut portions wherein one of said one or more additional said helical portions is connected to a second end of one of said strut portions, said one or more additional said helical portions being connected respectively to said one or more additional said strut portions such that each of said helical portions is interposed between a pair of said strut portions and at least one of said helical portions comprise helical elements which extend helically in a first direction from a first said strut portion to a peak and then in an opposite direction from said peak to a second said strut portion.
17. The stent of claim 16 wherein at least one of said helical portions comprises said helical elements being wound in a direction opposite to said helical elements of another of said helical portions.
18. The stent of claim 1 wherein said helical portion has a larger diameter than said strut portions.
19. The stent of claim 4 wherein at least one of said helical portions has a larger diameter than at least one of said strut portions.
20. The stent of claim 1 wherein said helical portion has a smaller diameter than said strut portion.
21. The stent of claim 4 wherein at least one of said helical portions has a smaller diameter than at least one of said strut portions.
22. The stent of claim 1 further comprising a biocompatible graft material covering an outside surface of said stent.
23. The stent of claim 1 further comprising a biocompatible graft material covering an inside surface of said stent.
24. The stent of claim 1 further comprising a biocompatible graft material covering and an outside surface and an inside surface of said stent.
25. The stent of claim 1 further comprising a biocompatible graft material attached to at least one of said strut portions, said graft material covering said strut portions and said helical portion.
26. The stent of claim 1 further comprising a plurality of sections of biocompatible graft material, each of said sections of graft material being attached to one of said strut portions and covering the attached said strut portion and a portion of an adjacent said helical portion wherein a gap is provided between each of said sections of graft material.
27. The stent of claim 26 wherein said gap is less than about 20% of a length of said helical portion.
28. The stent of claim 1 further comprising a plurality of sections of a biocompatible graft material, each of said sections of graft material being attached to one of said strut portions and covering the attached said strut portion and an adjacent said helical portion wherein said graft material of adjacent sections of graft material is overlapped.
29. The stent of claim 28 wherein said overlap is less than about 40% of a length of said helical portion.
30. The stent of claim 1 further comprising a biocompatible graft material, said graft material being attached to at least one of said strut portions, said graft material covering said strut portions and said helical portion and said graft material having a bulge at said helical portion.
31. The stent of claim 1 further comprising a biocompatible graft material, said graft material being attached to at least one of said strut portions, said graft material covering said strut portions and said helical portion and said graft material having a plurality longitudinal openings in said graft material over said helical portion.
32. The stent of claim 1 further comprising a biocompatible graft material, said graft material being attached to at least one of said strut portions and covering said strut portions and said helical portion, said graft material having a bulge at said helical portion and said graft material having a plurality of longitudinal openings in said graft material over said helical portion.
33. The stent of claim 32 further comprising a biocompatible graft material, said graft material being attached to at least one of said strut portions and covering said strut portions and said helical portion, said graft material having a plurality of helical openings corresponding to a pitch of said helical elements.
34. The stent of claim 1 further comprising a plurality of sections of biocompatible graft material each of said sections being attached to either said strut portion or said helical portion.
35. The stent of claim 34 wherein a gap is provided between each of said sections of said graft material.
36. The stent of claim 35 wherein said gap is less than about 20% of a length of said helical portion.
37. The stent of claim 1 further comprising a plurality of sections of biocompatible graft material each of said sections being attached to either said strut portion or said helical portion wherein adjacent sections of graft material are overlapped.
38. The stent of claim 37 wherein said overlap is less than about 40% of a length of said helical portion.
39. The stent of claim 1 wherein a gap between adjacent helical elements of a helical portion is about the same in a compressed state of said stent.
40. The stent of claim 39 wherein said gap is in a range of between 0 and a size of a gap between adjacent helical elements of a helical portion in said deployed state.
41. The stent of claim 1 wherein adjacent helical elements of a helical portion contact one another in a compressed state.
42. The stent of claim 1 wherein a gap between adjacent helical elements of a helical portion varies along the length of said helical portion in a compressed state.
43. The stent of claim 42 wherein said gap is in a range of between 0 and a size of a gap between adjacent helical elements of a helical portion in said deployed state.
44. The stent of claim 4 wherein said strut portions and/or said helical portions can have a varied axial length over a length of said stent.
45. The stent of claim 44 wherein said strut elements of said strut portion have a wave pattern of individual wave portions, each individual wave portion having a peak and each of said helical elements is connected to a respective one of said peaks on one side of said side strut elements and some of said helical elements are connected to some of said peaks on the other side of said side strut elements.
46. The stent of claim 45 wherein every other one of said peaks of said strut elements are connected by a respective one of said helical elements.
47. The stent of claim 4 wherein one of said helical portions has a higher ratio of a sum of gap lengths to a length of the helical portion than a second one of said helical portions.
48. The stent of claim 4 wherein one of said strut portions has less strut elements than a second of said strut portions.
49. The stent of claim 48 wherein said one of said strut portions has half as many strut elements as the second of said strut portions.
50. Flexible stent comprising:
a helical portion comprising a plurality of side-by-side, individual helical elements helically wound about an axis of said stent, said helical portion being expandable radially upon deployment and compressible, expandable and bendable in a deployed state; and a strut portion on either side of said helical portion, each of said strut portions comprising helically aligned strut elements having a first end connected to said helical elements of said helical portion, said strut portions being radially expandable upon deployment.
51. The stent of claim 50 wherein each of said helical elements extends for one or more complete rotations of 360 degrees about an axis of said stent.
52. The stent of claim 50 wherein each of said helical elements extends for at least 90 degrees about an axis of said stent.
53. A method for minimizing or eliminating foreshortening of a flexible stent comprising rotating a plurality of side-by-side individual helical elements, said helical elements being helically wound about an axis of said stent to form a helical portion, said helical portion being expandable radially upon deployment and compressible, expandable and bendable in a deployed state and a strut portion on either side of said helical portion, each of said strut portions comprising axially aligned strut elements having a first end connected to said helical elements of said helical portion, said strut portions being radially expandable upon deployment.
54. The method of claim 53 wherein an axial length of said stent in said deployed state is the same as an axial length of said stent in a crimped state.
55. The stent of claim 53 wherein a gap between said side-by-side helical elements of said helical portion is about the same in a crimped state of said stent.
56. The stent of claim 53 wherein said side-by-side helical elements of said helical portion contact one another in a crimped state of said stent.
57. The method of claim 56 wherein an axial length of said stent in said deployed state is the same as an axial length of said stent in a crimped state.
58. The method of claim 53 wherein an axial length of said stent in a crimped state is less than an axial length of said stent in said deployed state.
59. A method for crimping a flexible stent comprising elongating a plurality of side-by-side individual helical elements to a crimped state, said helical elements being helically wound about an axis of said stent to form a helical portion, said helical portion being expandable radially upon deployment and compressible, expandable and bendable in a deployed state and a strut portion on either side of said helical portion, each of said strut portions comprising axially aligned strut elements having a first end connected to said helical elements of said helical portion, said strut portions being radially expandable upon deployment.
60. The stent of claim 59 wherein a gap between said side-by-side helical elements of said helical portion varies along a length of said helical portion in said crimped state.
61. The method of claim 59 wherein an axial length of said stent in said deployed state is less than an axial length of said stent in said crimped state.
62. A method for placing a flexible stent within a mammal in a body lumen comprising placing one or more stents at said site, said flexible stent comprising a helical portion comprising a plurality of side-by-side, individual helical elements helically wound about an axis of said stent, said helical portion being expandable radially upon deployment and compressible, expandable and bendable in a deployed state; and a strut portion on either side of said helical portion, each of said strut portions comprising axially aligned strut elements having a first end connected to said helical elements of said helical section, said strut portions being radially expandable upon deployment.
63. The method of claim 62 wherein the mammal is a human and the body lumen is a vessel or duct.
64. The method of claim 62 wherein the mammal is a human and the body lumen is a super femoral artery.
65. The method of claim 62 wherein said stent further comprises a biocompatible graft material covering an outside surface of said stent and/or an inside surface of said stent.
66. A method of treating a diseased vessel or duct comprising the steps of:
guiding a catheter to a target site;
advancing through the catheter a flexible stent, said flexible stent comprising a helical portion comprising a plurality of side-by-side, individual helical elements helically wound about an axis of said stent, and a strut portion on either side of said helical portion, each of said strut portions comprising axially aligned strut elements having a first end connected to said helical elements of said helical section;
expelling the stent from the catheter at the target site, causing the helical portion to expand radially and said strut portions to expand radially, said helical portion being compressible, expandable and bendable in a deployed state.
67. The method of claim 66 wherein said target site is a vascular site.
68. The method of claim 66 wherein the target site is a super femoral artery.
69. The method of claim 66 wherein said target site is a lesion.
70. The method of claim 66 wherein said target site is an aneurysm.
71. The method of claim 66 wherein said stent further comprises a biocompatible graft material covering an outside surface of said stent and/or an inside surface of said stent.
72. The method of claim 66 wherein said stent further comprises a coating of a polymer and/or drug eluting material.
US12/884,514 2005-04-04 2010-09-17 Flexible stent Abandoned US20110029064A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/884,514 US20110029064A1 (en) 2005-04-04 2010-09-17 Flexible stent
US14/303,766 US9592137B2 (en) 2005-04-04 2014-06-13 Flexible stent

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66761305P 2005-04-04 2005-04-04
US25022605A 2005-10-14 2005-10-14
US11/397,987 US7803180B2 (en) 2005-04-04 2006-04-04 Flexible stent
US12/884,514 US20110029064A1 (en) 2005-04-04 2010-09-17 Flexible stent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/397,987 Division US7803180B2 (en) 2005-04-04 2006-04-04 Flexible stent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/303,766 Division US9592137B2 (en) 2005-04-04 2014-06-13 Flexible stent

Publications (1)

Publication Number Publication Date
US20110029064A1 true US20110029064A1 (en) 2011-02-03

Family

ID=37074053

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/397,987 Active 2029-02-07 US7803180B2 (en) 2005-04-04 2006-04-04 Flexible stent
US11/749,306 Active US7556644B2 (en) 2005-04-04 2007-05-16 Flexible stent
US12/884,514 Abandoned US20110029064A1 (en) 2005-04-04 2010-09-17 Flexible stent
US14/303,766 Active 2026-12-08 US9592137B2 (en) 2005-04-04 2014-06-13 Flexible stent

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/397,987 Active 2029-02-07 US7803180B2 (en) 2005-04-04 2006-04-04 Flexible stent
US11/749,306 Active US7556644B2 (en) 2005-04-04 2007-05-16 Flexible stent

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/303,766 Active 2026-12-08 US9592137B2 (en) 2005-04-04 2014-06-13 Flexible stent

Country Status (10)

Country Link
US (4) US7803180B2 (en)
EP (3) EP3613387B1 (en)
JP (1) JP5523700B2 (en)
CN (3) CN101484089B (en)
AU (1) AU2006231559B2 (en)
CA (1) CA2610108C (en)
ES (1) ES2764992T3 (en)
HK (1) HK1165257A1 (en)
NZ (1) NZ563119A (en)
WO (1) WO2006108010A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130268055A1 (en) * 2012-03-07 2013-10-10 Orbusneich Medical, Inc. Medical device for implantation into luminal structures
WO2014078536A1 (en) * 2012-11-15 2014-05-22 Palmaz Scientific, Inc. Stents having a hybrid pattern and methods of manufacture
WO2014066356A3 (en) * 2012-10-22 2014-06-19 Orbusneich Medical, Inc. Medical device for implantation into luminal structures
US8888841B2 (en) 2010-06-21 2014-11-18 Zorion Medical, Inc. Bioabsorbable implants
US20140379066A1 (en) * 2005-04-04 2014-12-25 Flexible Stenting Solutions, Inc. Flexible stent
US8986369B2 (en) 2010-12-01 2015-03-24 Zorion Medical, Inc. Magnesium-based absorbable implants
US9980835B2 (en) 2013-10-22 2018-05-29 Orbusneich Medical Inc. Medical device for implantation into luminal structures incorporating corrugated structural elements

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US7815763B2 (en) * 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20040267349A1 (en) 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
WO2004026183A2 (en) 2002-09-20 2004-04-01 Nellix, Inc. Stent-graft with positioning anchor
US9039755B2 (en) * 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US9155639B2 (en) 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US7763065B2 (en) 2004-07-21 2010-07-27 Reva Medical, Inc. Balloon expandable crush-recoverable stent device
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
US8597716B2 (en) * 2009-06-23 2013-12-03 Abbott Cardiovascular Systems Inc. Methods to increase fracture resistance of a drug-eluting medical device
US8292944B2 (en) 2004-12-17 2012-10-23 Reva Medical, Inc. Slide-and-lock stent
EP1903999B1 (en) 2005-04-25 2018-11-21 Covidien LP Controlled fracture connections for stents
JP2009500121A (en) 2005-07-07 2009-01-08 ネリックス・インコーポレーテッド System and method for treatment of an intraluminal aneurysm
US7914574B2 (en) 2005-08-02 2011-03-29 Reva Medical, Inc. Axially nested slide and lock expandable device
US9149378B2 (en) 2005-08-02 2015-10-06 Reva Medical, Inc. Axially nested slide and lock expandable device
US7704275B2 (en) 2007-01-26 2010-04-27 Reva Medical, Inc. Circumferentially nested expandable device
US20080221658A1 (en) * 2007-03-09 2008-09-11 Novostent Corporation Vascular prosthesis and methods of use
US8348994B2 (en) * 2007-03-09 2013-01-08 Novostent Corporation Vascular prosthesis with alternating helical sections
US8002815B2 (en) * 2007-03-09 2011-08-23 Novostent Corporation Delivery system and method for vascular prosthesis
US9017395B2 (en) * 2007-03-09 2015-04-28 Novostent Corporation Vascular prosthesis and methods of use
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US7988723B2 (en) 2007-08-02 2011-08-02 Flexible Stenting Solutions, Inc. Flexible stent
JP5216098B2 (en) 2007-11-30 2013-06-19 レヴァ メディカル、 インコーポレイテッド Axial and radially nested expandable device
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US8920488B2 (en) * 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
JP2011511701A (en) * 2008-02-13 2011-04-14 ネリックス・インコーポレーテッド Graft inner frame with axially variable properties
AU2009240419A1 (en) 2008-04-25 2009-10-29 Nellix, Inc. Stent graft delivery system
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
US20090319029A1 (en) * 2008-06-04 2009-12-24 Nellix, Inc. Docking apparatus and methods of use
JP2011522615A (en) 2008-06-04 2011-08-04 ネリックス・インコーポレーテッド Sealing device and method of use
US20150039072A1 (en) * 2008-07-31 2015-02-05 Bradley Beach Flexible stent
CN102164565B (en) * 2008-08-19 2014-07-23 帝秀简公司 Self-expanding medical device
WO2010024868A1 (en) * 2008-08-27 2010-03-04 Cook Incorporated Multi-section stent
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US9149377B2 (en) 2008-10-10 2015-10-06 Veryan Medical Ltd. Stent suitable for deployment in a blood vessel
EP2331014B1 (en) 2008-10-10 2017-08-09 Reva Medical, Inc. Expandable slide and lock stent
WO2010065241A1 (en) * 2008-12-02 2010-06-10 Boston Scientific Scimed, Inc. Stent with graduated stiffness
WO2010088676A1 (en) 2009-02-02 2010-08-05 Cordis Corporation Flexible stent design
WO2010124286A1 (en) * 2009-04-24 2010-10-28 Flexible Stenting Solutions, Inc. Flexible devices
EP2429453B1 (en) * 2009-05-14 2021-01-27 Orbusneich Medical Pte. Ltd Self-expanding stent with polygon transition zone
US8366765B2 (en) * 2009-09-18 2013-02-05 Medtronic Vascular, Inc. Helical stent with connections
US8114149B2 (en) * 2009-10-20 2012-02-14 Svelte Medical Systems, Inc. Hybrid stent with helical connectors
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8348987B2 (en) * 2009-12-22 2013-01-08 Cook Medical Technologies Llc Balloon with scoring member
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
WO2011127452A1 (en) 2010-04-10 2011-10-13 Reva Medical, Inc Expandable slide and lock stent
US8864811B2 (en) 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
US20120022578A1 (en) * 2010-07-20 2012-01-26 Cook Medical Technologies Llc Frame-based vena cava filter
JP5902165B2 (en) * 2010-08-02 2016-04-13 コーディス・コーポレイションCordis Corporation Flexible spiral stent with different spiral regions
US9233014B2 (en) * 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
US9028540B2 (en) 2011-03-25 2015-05-12 Covidien Lp Vascular stent with improved vessel wall apposition
EP2693980B1 (en) 2011-04-06 2022-07-13 Endologix LLC System for endovascular aneurysm treatment
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
CN102335052A (en) * 2011-07-15 2012-02-01 南京微创医学科技有限公司 Anti-restenosis digestive tract stent
NZ716708A (en) 2012-05-14 2016-08-26 Bard Inc C R Uniformly expandable stent
US9254205B2 (en) 2012-09-27 2016-02-09 Covidien Lp Vascular stent with improved vessel wall apposition
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
CA2905515C (en) 2013-03-14 2020-11-10 Palmaz Scientific, Inc. Monolithic medical devices, methods of making and using the same
US9408732B2 (en) 2013-03-14 2016-08-09 Reva Medical, Inc. Reduced-profile slide and lock stent
JP6533776B2 (en) 2013-03-14 2019-06-19 エンドーロジックス インコーポレイテッド System for treating an aneurysm in a patient's body and method of operating the same
DE102013104062A1 (en) 2013-04-22 2014-10-23 Novatech Sa stent
CN105451691B (en) * 2013-06-21 2018-07-17 波士顿科学国际有限公司 Holder with deflection connector
JP5586742B1 (en) * 2013-06-28 2014-09-10 株式会社World Medish High flexibility stent
EP3184084B1 (en) 2013-09-12 2020-04-01 Boston Scientific Scimed, Inc. Stent with anti-migration connectors
JP5550028B1 (en) * 2014-01-27 2014-07-16 株式会社World Medish High flexibility stent
JP5695259B1 (en) 2014-02-19 2015-04-01 株式会社World Medish High flexibility stent
USD888245S1 (en) 2014-03-14 2020-06-23 Vactronix Scientific, Llc Stent device
CN106456347B (en) 2014-03-18 2018-11-13 波士顿科学国际有限公司 Reduce the support Design of granulation and inflammation
US10219921B2 (en) 2014-10-02 2019-03-05 Boston Scientific Scimed, Inc. Controlled ingrowth feature for antimigration
JP2017530811A (en) 2014-10-22 2017-10-19 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Flexible hinged stent
WO2016073597A1 (en) 2014-11-06 2016-05-12 Boston Scientific Scimed, Inc. Tracheal stent
CN104490500B (en) * 2014-12-25 2017-01-18 周玉杰 Chain type coronary stent suitable for coronary artery tortuosity angulation lesion
JP6734097B2 (en) * 2015-03-31 2020-08-05 康宏 正林 Highly flexible stent
EP3763340A1 (en) * 2016-03-24 2021-01-13 Covidien LP Vascular flow diversion
US11628077B2 (en) * 2016-10-31 2023-04-18 Razmodics Llc Post deployment radial force recovery of biodegradable scaffolds
US10342686B2 (en) * 2017-08-10 2019-07-09 Covidien Lp Thin film mesh hybrid for treating vascular defects
CN109662819B (en) * 2019-01-31 2021-08-06 深圳市科奕顿生物医疗科技有限公司 Self-expanding stent and preparation method and application thereof
CN109662820B (en) * 2019-01-31 2023-06-16 深圳市科奕顿生物医疗科技有限公司 Self-expanding stent and preparation method and application thereof
JP2023510553A (en) 2020-01-13 2023-03-14 ボストン サイエンティフィック サイムド,インコーポレイテッド anti-migration stent
CN113017753A (en) * 2021-02-26 2021-06-25 珠海通桥医疗科技有限公司 Blood vessel support

Citations (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5669932A (en) * 1996-05-29 1997-09-23 Isostent, Inc. Means for accurately positioning an expandable stent
US5693085A (en) * 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5749919A (en) * 1994-01-10 1998-05-12 Microfil Industries S.A. Resilient prosthesis for widening a channel, particularly a blood vessel, and method for making same
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5810872A (en) * 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US5824059A (en) * 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6033433A (en) * 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
US6039756A (en) * 1996-04-26 2000-03-21 Jang; G. David Intravascular stent
US6042597A (en) * 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6146417A (en) * 1996-08-22 2000-11-14 Ischinger; Thomas Tubular stent
US6152957A (en) * 1996-04-26 2000-11-28 Jang; G. David Intravascular stent
US6231598B1 (en) * 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6245101B1 (en) * 1999-05-03 2001-06-12 William J. Drasler Intravascular hinge stent
US6261319B1 (en) * 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US6302907B1 (en) * 1999-10-05 2001-10-16 Scimed Life Systems, Inc. Flexible endoluminal stent and process of manufacture
US20010039447A1 (en) * 2000-03-01 2001-11-08 Pinchasik Gregory A. Longitudinally flexible stent
US6352552B1 (en) * 2000-05-02 2002-03-05 Scion Cardio-Vascular, Inc. Stent
US20020082682A1 (en) * 2000-12-19 2002-06-27 Vascular Architects, Inc. Biologically active agent delivery apparatus and method
US20020095207A1 (en) * 2001-01-15 2002-07-18 Yousuke Moriuchi Stent
US6423091B1 (en) * 2000-05-16 2002-07-23 Cordis Corporation Helical stent having flat ends
US20020143390A1 (en) * 2001-03-30 2002-10-03 Tatsuzo Ishii Stent
US6551351B2 (en) * 1999-07-02 2003-04-22 Scimed Life Systems Spiral wound stent
US20030114920A1 (en) * 1999-12-21 2003-06-19 Caro Colin Gerald Vascular stents
US6585758B1 (en) * 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US20030144729A1 (en) * 2002-01-30 2003-07-31 Scimed Life Systems, Inc. Stent with wishbone connectors and serpentine bands
US6602281B1 (en) * 1995-06-05 2003-08-05 Avantec Vascular Corporation Radially expansible vessel scaffold having beams and expansion joints
US6632236B2 (en) * 1999-03-12 2003-10-14 Arteria Medical Science, Inc. Catheter having radially expandable main body
US20030195609A1 (en) * 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
US20030204244A1 (en) * 2002-04-26 2003-10-30 Stiger Mark L. Aneurysm exclusion stent
US20040002753A1 (en) * 2002-06-28 2004-01-01 Robert Burgermeister Stent with diagonal flexible connecting links
US6679911B2 (en) * 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US20040034402A1 (en) * 2002-07-26 2004-02-19 Syntheon, Llc Helical stent having flexible transition zone
US20040088044A1 (en) * 1995-03-01 2004-05-06 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
US20040122504A1 (en) * 2002-12-24 2004-06-24 Michael Hogendijk Vascular prosthesis and methods of use
US20040172123A1 (en) * 2002-12-20 2004-09-02 Biotronik Gmbh & Co. Kg Stent
US20040186556A1 (en) * 2002-12-24 2004-09-23 Novostent Corporation Vascular prosthesis and methods of use
US20050033410A1 (en) * 2002-12-24 2005-02-10 Novostent Corporation Vascular prothesis having flexible configuration
US6878162B2 (en) * 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US20060020322A1 (en) * 2004-07-21 2006-01-26 Alexander Leynov Expandable framework with overlapping connectors
US20060247759A1 (en) * 2005-04-04 2006-11-02 Janet Burpee Flexible stent
US7131993B2 (en) * 2003-06-25 2006-11-07 Boston Scientific Scimed, Inc. Varying circumferential spanned connectors in a stent
US7169175B2 (en) * 2000-05-22 2007-01-30 Orbusneich Medical, Inc. Self-expanding stent
US7179286B2 (en) * 2003-02-21 2007-02-20 Boston Scientific Scimed, Inc. Stent with stepped connectors
US7208009B2 (en) * 1996-12-26 2007-04-24 Medinol, Ltd. Stent fabrication method
US7217286B2 (en) * 1997-04-18 2007-05-15 Cordis Corporation Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent
US20070129786A1 (en) * 2005-10-14 2007-06-07 Bradley Beach Helical stent
US20090036976A1 (en) * 2007-08-02 2009-02-05 Bradley Beach Flexible stent
US7637939B2 (en) * 2005-06-30 2009-12-29 Boston Scientific Scimed, Inc. Hybrid stent
US20100286760A1 (en) * 2009-04-24 2010-11-11 Bradley Beach Flexible devices

Family Cites Families (210)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4432132A (en) * 1981-12-07 1984-02-21 Bell Telephone Laboratories, Incorporated Formation of sidewall oxide layers by reactive oxygen ion etching to define submicron features
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US4813925A (en) 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5266073A (en) 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
CA2026604A1 (en) 1989-10-02 1991-04-03 Rodney G. Wolff Articulated stent
US5190540A (en) 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
WO1995014500A1 (en) 1992-05-01 1995-06-01 Beth Israel Hospital A stent
CA2157936C (en) 1993-03-11 2004-11-02 Gregory Pinchasik Stent
US5913897A (en) 1993-09-16 1999-06-22 Cordis Corporation Endoprosthesis having multiple bridging junctions and procedure
GB2281865B (en) 1993-09-16 1997-07-30 Cordis Corp Endoprosthesis having multiple laser welded junctions,method and procedure
US5989280A (en) 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
EP0997115B1 (en) * 1994-04-01 2003-10-29 Prograft Medical, Inc. Self-expandable stent and stent-graft and method of preparing them
US6165210A (en) 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
DE69528216T2 (en) 1994-06-17 2003-04-17 Terumo Corp Process for the production of a permanent stent
EP0794726A4 (en) 1994-10-20 1998-01-07 Instent Inc Cystoscope delivery system
US5836964A (en) 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
IL115756A0 (en) * 1994-10-27 1996-01-19 Medinol Ltd Stent fabrication method
CA2301351C (en) 1994-11-28 2002-01-22 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
ATE220308T1 (en) 1995-03-01 2002-07-15 Scimed Life Systems Inc LONGITUDONLY FLEXIBLE AND EXPANDABLE STENT
US6896696B2 (en) 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
WO1996032078A1 (en) 1995-04-14 1996-10-17 Schneider (Usa) Inc. Rolling membrane stent delivery device
CZ292021B6 (en) * 1995-04-26 2003-07-16 Medinol Ltd. Connector for connecting adjacent areas of adjacent segments of an articulated stent and the articulated stent per se
CN1140227C (en) * 1995-04-26 2004-03-03 梅迪诺尔有限公司 Articulated stent
US5788707A (en) 1995-06-07 1998-08-04 Scimed Life Systems, Inc. Pull back sleeve system with compression resistant inner shaft
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
WO1997014375A1 (en) 1995-10-20 1997-04-24 Bandula Wijay Vascular stent
US5913896A (en) 1995-11-28 1999-06-22 Medtronic, Inc. Interwoven dual sinusoidal helix stent
ZA9610721B (en) 1995-12-21 1998-06-19 Cornell Res Foundation Inc Grapevine leafroll virus proteins and their uses.
EP1011889B1 (en) 1996-01-30 2002-10-30 Medtronic, Inc. Articles for and methods of making stents
WO1997032544A1 (en) 1996-03-05 1997-09-12 Divysio Solutions Ulc. Expandable stent and method for delivery of same
JP3815622B2 (en) 1996-03-07 2006-08-30 エム イー ディー インスティチュート,インク Inflatable stent
US6334871B1 (en) 1996-03-13 2002-01-01 Medtronic, Inc. Radiopaque stent markers
IL117472A0 (en) 1996-03-13 1996-07-23 Instent Israel Ltd Radiopaque stent markers
US5649949A (en) 1996-03-14 1997-07-22 Target Therapeutics, Inc. Variable cross-section conical vasoocclusive coils
US5833699A (en) 1996-04-10 1998-11-10 Chuter; Timothy A. M. Extending ribbon stent
FR2747301B1 (en) 1996-04-10 1998-09-18 Nycomed Lab Sa IMPLANTABLE DEVICE FOR MAINTAINING OR RE-ESTABLISHING THE NORMAL PASSAGE SECTION OF A BODY DUCT, AS WELL AS A SYSTEM FOR ITS PLACEMENT
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5807404A (en) 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US5776142A (en) 1996-12-19 1998-07-07 Medtronic, Inc. Controllable stent delivery system and method
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
FR2758253B1 (en) 1997-01-10 1999-04-02 Nycomed Lab Sa IMPLANTABLE DEVICE FOR THE TREATMENT OF A BODY DUCT
US5925061A (en) 1997-01-13 1999-07-20 Gore Enterprise Holdings, Inc. Low profile vascular stent
US6241757B1 (en) 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
DE69839498D1 (en) 1997-02-11 2008-06-26 Warsaw Orthopedic Inc Plate for the anterior cervical spine with fixation system for one screw
FR2760351B1 (en) 1997-03-04 1999-05-28 Bernard Glatt HELICAL STENT FORMING DEVICE AND MANUFACTURING METHOD THEREOF
US5911732A (en) 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5792144A (en) 1997-03-31 1998-08-11 Cathco, Inc. Stent delivery catheter system
US5718713A (en) 1997-04-10 1998-02-17 Global Therapeutics, Inc. Surgical stent having a streamlined contour
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
DE29708879U1 (en) 1997-05-20 1997-07-31 Jomed Implantate Gmbh Coronary stent
US5891192A (en) 1997-05-22 1999-04-06 The Regents Of The University Of California Ion-implanted protein-coated intralumenal implants
BE1011180A6 (en) 1997-05-27 1999-06-01 Medicorp R & D Benelux Sa Luminal endoprosthesis AUTO EXPANDABLE.
US5913895A (en) 1997-06-02 1999-06-22 Isostent, Inc. Intravascular stent with enhanced rigidity strut members
EP0884029B1 (en) 1997-06-13 2004-12-22 Gary J. Becker Expandable intraluminal endoprosthesis
US5843175A (en) 1997-06-13 1998-12-01 Global Therapeutics, Inc. Enhanced flexibility surgical stent
EP0890346A1 (en) 1997-06-13 1999-01-13 Gary J. Becker Expandable intraluminal endoprosthesis
FR2764794B1 (en) 1997-06-20 1999-11-12 Nycomed Lab Sa EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS
IL121316A (en) 1997-07-15 2001-07-24 Litana Ltd Implantable medical device of shape memory alloy
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
NO311781B1 (en) 1997-11-13 2002-01-28 Medinol Ltd Metal multilayer stents
US6156062A (en) 1997-12-03 2000-12-05 Ave Connaught Helically wrapped interlocking stent
US6022374A (en) 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US6190406B1 (en) 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
US6719779B2 (en) 2000-11-07 2004-04-13 Innercool Therapies, Inc. Circulation set for temperature-controlled catheter and method of using the same
US6533807B2 (en) 1998-02-05 2003-03-18 Medtronic, Inc. Radially-expandable stent and delivery system
US6676696B1 (en) 1998-02-12 2004-01-13 Thomas R. Marotta Endovascular prosthesis
JP4801838B2 (en) 1998-03-05 2011-10-26 ボストン サイエンティフィック リミテッド Intraluminal stent
US6019778A (en) 1998-03-13 2000-02-01 Cordis Corporation Delivery apparatus for a self-expanding stent
US7179289B2 (en) 1998-03-30 2007-02-20 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6264687B1 (en) 1998-04-20 2001-07-24 Cordis Corporation Multi-laminate stent having superelastic articulated sections
US6168621B1 (en) 1998-05-29 2001-01-02 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6740113B2 (en) 1998-05-29 2004-05-25 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
CA2334223C (en) 1998-06-04 2008-11-18 New York University Endovascular thin film devices and methods for treating and preventing stroke
DE19839646A1 (en) 1998-08-31 2000-03-09 Jomed Implantate Gmbh Stent
US6093194A (en) 1998-09-14 2000-07-25 Endocare, Inc. Insertion device for stents and methods for use
DE29816878U1 (en) 1998-09-21 1998-12-24 Schmitz Rode Thomas Dipl Ing D Helix stent that can be manufactured using the cutting process
US6059813A (en) 1998-11-06 2000-05-09 Scimed Life Systems, Inc. Rolling membrane stent delivery system
US6544278B1 (en) 1998-11-06 2003-04-08 Scimed Life Systems, Inc. Rolling membrane stent delivery system
CA2289169A1 (en) 1998-11-11 2000-05-11 Ogawa Spring Co., Ltd. Stent, manufacturing method thereof and indwelling method thereof
WO2000030563A1 (en) * 1998-11-20 2000-06-02 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
SG75982A1 (en) 1998-12-03 2000-10-24 Medinol Ltd Controlled detachment stents
US6503270B1 (en) 1998-12-03 2003-01-07 Medinol Ltd. Serpentine coiled ladder stent
US6355059B1 (en) 1998-12-03 2002-03-12 Medinol, Ltd. Serpentine coiled ladder stent
US6743252B1 (en) 1998-12-18 2004-06-01 Cook Incorporated Cannula stent
US6254609B1 (en) 1999-01-11 2001-07-03 Scimed Life Systems, Inc. Self-expanding stent delivery system with two sheaths
EP1020166A1 (en) 1999-01-12 2000-07-19 Orbus Medical Technologies, Inc. Expandable intraluminal endoprosthesis
US6287333B1 (en) 1999-03-15 2001-09-11 Angiodynamics, Inc. Flexible stent
US6899730B1 (en) 1999-04-15 2005-05-31 Scimed Life Systems, Inc. Catheter-stent device
US6860899B1 (en) 1999-04-15 2005-03-01 Boston Scientific Scimed, Inc. Method for treating neurovascular aneurysms
US6730116B1 (en) 1999-04-16 2004-05-04 Medtronic, Inc. Medical device for intraluminal endovascular stenting
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6673103B1 (en) 1999-05-20 2004-01-06 Scimed Life Systems, Inc. Mesh and stent for increased flexibility
US6485507B1 (en) 1999-07-28 2002-11-26 Scimed Life Systems Multi-property nitinol by heat treatment
US6142987A (en) 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
WO2001026584A1 (en) 1999-10-14 2001-04-19 United Stenting, Inc. Stents with multilayered struts
US6171328B1 (en) 1999-11-09 2001-01-09 Embol-X, Inc. Intravascular catheter filter with interlocking petal design and methods of use
US6264671B1 (en) 1999-11-15 2001-07-24 Advanced Cardiovascular Systems, Inc. Stent delivery catheter and method of use
CN1186423C (en) 1999-12-03 2005-01-26 中国科学院南京土壤研究所 Process for preparing ammonia suppressing film of rice field
US6334866B1 (en) 2000-01-14 2002-01-01 William H. Wall Stent device for performing endovascular repair of aneurysms
US7758627B2 (en) 2000-03-01 2010-07-20 Medinol, Ltd. Longitudinally flexible stent
US7828835B2 (en) 2000-03-01 2010-11-09 Medinol Ltd. Longitudinally flexible stent
US6723119B2 (en) 2000-03-01 2004-04-20 Medinol Ltd. Longitudinally flexible stent
US6953476B1 (en) 2000-03-27 2005-10-11 Neovasc Medical Ltd. Device and method for treating ischemic heart disease
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
AU2001275100A1 (en) 2000-05-31 2001-12-11 Courtney, Brian K. Embolization protection system for vascular procedures
US8298257B2 (en) 2000-06-29 2012-10-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US6540775B1 (en) 2000-06-30 2003-04-01 Cordis Corporation Ultraflexible open cell stent
US6969401B1 (en) 2000-08-18 2005-11-29 Marotta Thomas R Endovascular prosthesis
US6565595B1 (en) 2000-09-18 2003-05-20 Scimed Life Systems, Inc. Two component sleeves
US6607552B1 (en) 2000-09-18 2003-08-19 Scimed Life Systems, Inc. Rolling socks
US6805898B1 (en) 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
US6492615B1 (en) 2000-10-12 2002-12-10 Scimed Life Systems, Inc. Laser polishing of medical devices
US7163552B2 (en) 2000-10-13 2007-01-16 Medtronic Vascular, Inc. Stent delivery system with hydraulic deployment
US6663664B1 (en) 2000-10-26 2003-12-16 Advanced Cardiovascular Systems, Inc. Self-expanding stent with time variable radial force
US6506211B1 (en) 2000-11-13 2003-01-14 Scimed Life Systems, Inc. Stent designs
US6843802B1 (en) 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent
US6579308B1 (en) 2000-11-28 2003-06-17 Scimed Life Systems, Inc. Stent devices with detachable distal or proximal wires
US6517567B2 (en) 2000-11-30 2003-02-11 Albert R. Bass, Jr. Apparatus and method for pacifier withdrawal
JP4727070B2 (en) 2001-06-01 2011-07-20 テルモ株式会社 Stent
JP4323102B2 (en) 2001-01-15 2009-09-02 テルモ株式会社 Flexible stent
US7169165B2 (en) 2001-01-16 2007-01-30 Boston Scientific Scimed, Inc. Rapid exchange sheath for deployment of medical devices and methods of use
US6899727B2 (en) 2001-01-22 2005-05-31 Gore Enterprise Holdings, Inc. Deployment system for intraluminal devices
US6736839B2 (en) 2001-02-01 2004-05-18 Charles Cummings Medical device delivery system
US6563080B2 (en) 2001-02-15 2003-05-13 Scimed Life Systems, Inc. Laser cutting of stents and other medical devices
US6613077B2 (en) 2001-03-27 2003-09-02 Scimed Life Systems, Inc. Stent with controlled expansion
GB0107910D0 (en) 2001-03-29 2001-05-23 Isis Innovation Deployable stent
US7105199B2 (en) 2001-05-11 2006-09-12 Exogenesis Corporation Methods of adhering drugs to the surface of medical devices through ion beam surface modification
US6599314B2 (en) 2001-06-08 2003-07-29 Cordis Corporation Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
US6612012B2 (en) 2001-06-11 2003-09-02 Cordis Neurovascular, Inc. Method of manufacturing small profile medical devices
US6818013B2 (en) 2001-06-14 2004-11-16 Cordis Corporation Intravascular stent device
US6673106B2 (en) 2001-06-14 2004-01-06 Cordis Neurovascular, Inc. Intravascular stent device
US6796999B2 (en) 2001-09-06 2004-09-28 Medinol Ltd. Self articulating stent
IL160817A0 (en) 2001-09-10 2004-08-31 Medinol Ltd Longitudinally flexible stent
US7175655B1 (en) 2001-09-17 2007-02-13 Endovascular Technologies, Inc. Avoiding stress-induced martensitic transformation in nickel titanium alloys used in medical devices
US20030229390A1 (en) 2001-09-17 2003-12-11 Control Delivery Systems, Inc. On-stent delivery of pyrimidines and purine analogs
JP3605388B2 (en) 2001-10-16 2004-12-22 川澄化学工業株式会社 Stent
US20050070992A1 (en) 2001-11-28 2005-03-31 Aptus Endosystems, Inc. Prosthesis systems and methods sized and configured for the receipt and retention of fasteners
JP4331610B2 (en) 2001-12-20 2009-09-16 トリバスキュラー2,インコーポレイティド Advanced endovascular graft
US7163553B2 (en) 2001-12-28 2007-01-16 Advanced Cardiovascular Systems, Inc. Intravascular stent and method of use
US6981985B2 (en) 2002-01-22 2006-01-03 Boston Scientific Scimed, Inc. Stent bumper struts
US7445629B2 (en) 2002-01-31 2008-11-04 Boston Scientific Scimed, Inc. Medical device for delivering biologically active material
US7169170B2 (en) 2002-02-22 2007-01-30 Cordis Corporation Self-expanding stent delivery system
US7052511B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Delivery system and method for deployment of foreshortening endoluminal devices
DE10219014A1 (en) 2002-04-27 2003-11-13 Ruesch Willy Gmbh Self-expanding stent for reinforcing and/or keeping open a hollow organ comprise two elastic tubular layers which bracket and positionally fix at least one helical filament
US7122048B2 (en) 2002-05-03 2006-10-17 Scimed Life Systems, Inc. Hypotube endoluminal device
EP1503700B1 (en) 2002-05-08 2012-09-26 Abbott Laboratories Endoprosthesis having foot extensions
AU2003243204B2 (en) 2002-05-16 2008-09-18 Cook Medical Technologies Llc Flexible barb for anchoring a prosthesis
US7055612B2 (en) 2002-05-17 2006-06-06 The Viking Corporation Fire protection system
US6830638B2 (en) 2002-05-24 2004-12-14 Advanced Cardiovascular Systems, Inc. Medical devices configured from deep drawn nickel-titanium alloys and nickel-titanium clad alloys and method of making the same
US20040002752A1 (en) 2002-06-26 2004-01-01 Scimed Life Systems, Inc. Sacrificial anode stent system
US6761731B2 (en) 2002-06-28 2004-07-13 Cordis Corporation Balloon-stent interaction to help reduce foreshortening
ATE281800T1 (en) 2002-09-09 2004-11-15 Abbott Lab Vascular Entpr Ltd SYSTEM FOR INSERTING A SELF-EXPANDING STENT
US8444666B2 (en) 2002-09-12 2013-05-21 Cook Medical Technologies Llc Retrievable filter
US7001422B2 (en) 2002-09-23 2006-02-21 Cordis Neurovascular, Inc Expandable stent and delivery system
US7135038B1 (en) 2002-09-30 2006-11-14 Advanced Cardiovascular Systems, Inc. Drug eluting stent
US7169172B2 (en) 2002-11-01 2007-01-30 Counter Clockwise, Inc. Method and apparatus for caged stent delivery
US7169178B1 (en) 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
US6923829B2 (en) 2002-11-25 2005-08-02 Advanced Bio Prosthetic Surfaces, Ltd. Implantable expandable medical devices having regions of differential mechanical properties and methods of making same
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7044965B1 (en) 2002-12-13 2006-05-16 Spielberg Theodore E Therapeutic cellular stent
AU2003301005A1 (en) 2002-12-16 2004-07-22 The Regents Of The University Of Michigan Assembly and planar structure for use therein which is expandable into a 3-d structure such as a stent and device for making the planar structure
US20040147998A1 (en) 2003-01-24 2004-07-29 Nolting John E. Differentially coated stent
US7942920B2 (en) 2003-02-25 2011-05-17 Cordis Corporation Stent with nested fingers for enhanced vessel coverage
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7591832B2 (en) 2003-04-24 2009-09-22 Medtronic, Inc. Expandable guide sheath and apparatus with distal protection and methods for use
KR100561713B1 (en) 2003-05-23 2006-03-20 (주) 태웅메디칼 Flexible self-expandable stent and methods for making the stent
US7112216B2 (en) * 2003-05-28 2006-09-26 Boston Scientific Scimed, Inc. Stent with tapered flexibility
US20040260377A1 (en) 2003-06-17 2004-12-23 Medinol, Ltd. Shape memory alloy endoprosthesis delivery system
US20040260384A1 (en) 2003-06-17 2004-12-23 Medtronic Ave Superelastic coiled stent
US6945990B2 (en) 2003-08-16 2005-09-20 Medtronic Vascular, Inc. Double sheath deployment system
US20050080479A1 (en) 2003-09-29 2005-04-14 Feng James Q. Expandable endovascular stent
US7060090B2 (en) 2003-10-15 2006-06-13 Medtronic Vascular, Inc. Stent with increased longitudinal flexibility and scaffolding
US20050090888A1 (en) 2003-10-28 2005-04-28 Hines Richard A. Pleated stent assembly
US7316711B2 (en) 2003-10-29 2008-01-08 Medtronic Vascular, Inc. Intralumenal stent device for use in body lumens of various diameters
US20050096725A1 (en) 2003-10-29 2005-05-05 Pomeranz Mark L. Expandable stent having removable slat members
US20050125025A1 (en) 2003-12-05 2005-06-09 Marcel Rioux Styptic device
US7873400B2 (en) 2003-12-10 2011-01-18 Stryker Leibinger Gmbh & Co. Kg. Adapter for surgical navigation trackers
US20050131530A1 (en) 2003-12-15 2005-06-16 Darack Ed E. Endoluminal stent
WO2005063251A1 (en) 2003-12-17 2005-07-14 Pfizer Products Inc. Modified stent useful for delivery of drugs along stent strut
US7243408B2 (en) 2004-02-09 2007-07-17 Boston Scientific Scimed, Inc. Process method for attaching radio opaque markers to shape memory stent
US7766960B2 (en) * 2004-04-30 2010-08-03 Novostent Corporation Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use
US7763064B2 (en) 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
JP2006029900A (en) 2004-07-14 2006-02-02 Tdk Corp Magnetic sensor for encoder
US8308789B2 (en) 2004-07-16 2012-11-13 W. L. Gore & Associates, Inc. Deployment system for intraluminal devices
US7323008B2 (en) 2004-08-09 2008-01-29 Medtronic Vascular, Inc. Flexible stent
US20060064155A1 (en) 2004-09-01 2006-03-23 Pst, Llc Stent and method for manufacturing the stent
US20060074480A1 (en) 2004-09-01 2006-04-06 Pst, Llc Stent and method for manufacturing the stent
US7018403B1 (en) 2004-09-14 2006-03-28 Advanced Cardiovascular Systems, Inc. Inclined stent pattern for vulnerable plaque
US7914570B2 (en) 2004-10-07 2011-03-29 Boston Scientific Scimed, Inc. Non-shortening helical stent
EP1819300B1 (en) 2004-10-26 2012-07-04 Cordis Corporation Stent having phased hoop sections
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7918880B2 (en) 2005-02-16 2011-04-05 Boston Scientific Scimed, Inc. Self-expanding stent and delivery system
WO2006093976A1 (en) 2005-02-28 2006-09-08 Spirus Medical Inc. Rotate-to-advance catheterization system
US20070055365A1 (en) 2005-04-28 2007-03-08 The Cleveland Clinic Foundation Stent with integrated filter
US20070027522A1 (en) 2005-06-14 2007-02-01 Chang Jean C Stent delivery and guidewire systems

Patent Citations (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5749919A (en) * 1994-01-10 1998-05-12 Microfil Industries S.A. Resilient prosthesis for widening a channel, particularly a blood vessel, and method for making same
US5980552A (en) * 1994-03-17 1999-11-09 Medinol Ltd. Articulated stent
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5693085A (en) * 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US20040088044A1 (en) * 1995-03-01 2004-05-06 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
US6602281B1 (en) * 1995-06-05 2003-08-05 Avantec Vascular Corporation Radially expansible vessel scaffold having beams and expansion joints
US6152957A (en) * 1996-04-26 2000-11-28 Jang; G. David Intravascular stent
US6039756A (en) * 1996-04-26 2000-03-21 Jang; G. David Intravascular stent
US5669932A (en) * 1996-05-29 1997-09-23 Isostent, Inc. Means for accurately positioning an expandable stent
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US6146417A (en) * 1996-08-22 2000-11-14 Ischinger; Thomas Tubular stent
US7208009B2 (en) * 1996-12-26 2007-04-24 Medinol, Ltd. Stent fabrication method
US5810872A (en) * 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US7217286B2 (en) * 1997-04-18 2007-05-15 Cordis Corporation Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent
US6033433A (en) * 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
US5824059A (en) * 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
US6231598B1 (en) * 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6261319B1 (en) * 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US6478816B2 (en) * 1998-07-08 2002-11-12 Scimed Life Systems, Inc. Stent
US6945993B2 (en) * 1998-07-08 2005-09-20 Boston Scientific Scimed, Inc. Stent
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6949120B2 (en) * 1998-10-23 2005-09-27 Scimed Life Systems, Inc. Helical stent design
US6042597A (en) * 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6488703B1 (en) * 1998-10-23 2002-12-03 Scimed Life Systems, Inc. Helical stent design
US20030050690A1 (en) * 1998-10-23 2003-03-13 Kveen Graig L. Helical stent design
US20050216076A1 (en) * 1998-10-23 2005-09-29 Boston Scientific Scimed, Inc. Helical stent design
US6632236B2 (en) * 1999-03-12 2003-10-14 Arteria Medical Science, Inc. Catheter having radially expandable main body
US6475237B2 (en) * 1999-05-03 2002-11-05 William J. Drasler Intravascular hinge stent
US6245101B1 (en) * 1999-05-03 2001-06-12 William J. Drasler Intravascular hinge stent
US6551351B2 (en) * 1999-07-02 2003-04-22 Scimed Life Systems Spiral wound stent
US6302907B1 (en) * 1999-10-05 2001-10-16 Scimed Life Systems, Inc. Flexible endoluminal stent and process of manufacture
US20030149473A1 (en) * 1999-11-16 2003-08-07 Chouinard Paul F. Multi-section filamentary endoluminal stent
US6585758B1 (en) * 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US20030114920A1 (en) * 1999-12-21 2003-06-19 Caro Colin Gerald Vascular stents
US20010039447A1 (en) * 2000-03-01 2001-11-08 Pinchasik Gregory A. Longitudinally flexible stent
US6352552B1 (en) * 2000-05-02 2002-03-05 Scion Cardio-Vascular, Inc. Stent
US6423091B1 (en) * 2000-05-16 2002-07-23 Cordis Corporation Helical stent having flat ends
US7169175B2 (en) * 2000-05-22 2007-01-30 Orbusneich Medical, Inc. Self-expanding stent
US20020082682A1 (en) * 2000-12-19 2002-06-27 Vascular Architects, Inc. Biologically active agent delivery apparatus and method
US20020095207A1 (en) * 2001-01-15 2002-07-18 Yousuke Moriuchi Stent
US6679911B2 (en) * 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US20020143390A1 (en) * 2001-03-30 2002-10-03 Tatsuzo Ishii Stent
US20030144729A1 (en) * 2002-01-30 2003-07-31 Scimed Life Systems, Inc. Stent with wishbone connectors and serpentine bands
US20030195609A1 (en) * 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
US20030204244A1 (en) * 2002-04-26 2003-10-30 Stiger Mark L. Aneurysm exclusion stent
US20040002753A1 (en) * 2002-06-28 2004-01-01 Robert Burgermeister Stent with diagonal flexible connecting links
US20040034402A1 (en) * 2002-07-26 2004-02-19 Syntheon, Llc Helical stent having flexible transition zone
US6969402B2 (en) * 2002-07-26 2005-11-29 Syntheon, Llc Helical stent having flexible transition zone
US6878162B2 (en) * 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US20040172123A1 (en) * 2002-12-20 2004-09-02 Biotronik Gmbh & Co. Kg Stent
US20040122504A1 (en) * 2002-12-24 2004-06-24 Michael Hogendijk Vascular prosthesis and methods of use
US20050033410A1 (en) * 2002-12-24 2005-02-10 Novostent Corporation Vascular prothesis having flexible configuration
US20040186556A1 (en) * 2002-12-24 2004-09-23 Novostent Corporation Vascular prosthesis and methods of use
US7179286B2 (en) * 2003-02-21 2007-02-20 Boston Scientific Scimed, Inc. Stent with stepped connectors
US7131993B2 (en) * 2003-06-25 2006-11-07 Boston Scientific Scimed, Inc. Varying circumferential spanned connectors in a stent
US20060020322A1 (en) * 2004-07-21 2006-01-26 Alexander Leynov Expandable framework with overlapping connectors
US20060247759A1 (en) * 2005-04-04 2006-11-02 Janet Burpee Flexible stent
US20070208416A1 (en) * 2005-04-04 2007-09-06 Janet Burpee Flexible stent
US7803180B2 (en) * 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US7556644B2 (en) * 2005-04-04 2009-07-07 Flexible Stenting Solutions, Inc. Flexible stent
US7637939B2 (en) * 2005-06-30 2009-12-29 Boston Scientific Scimed, Inc. Hybrid stent
US20070129786A1 (en) * 2005-10-14 2007-06-07 Bradley Beach Helical stent
US20090036976A1 (en) * 2007-08-02 2009-02-05 Bradley Beach Flexible stent
US7988723B2 (en) * 2007-08-02 2011-08-02 Flexible Stenting Solutions, Inc. Flexible stent
US20110245910A1 (en) * 2007-08-02 2011-10-06 Bradley Beach Flexible stent
US8500794B2 (en) * 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
US20100286760A1 (en) * 2009-04-24 2010-11-11 Bradley Beach Flexible devices

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140379066A1 (en) * 2005-04-04 2014-12-25 Flexible Stenting Solutions, Inc. Flexible stent
US9592137B2 (en) * 2005-04-04 2017-03-14 Flexible Stenting Solutions, Inc. Flexible stent
US9849008B2 (en) 2010-06-21 2017-12-26 Zorion Medical, Inc. Bioabsorbable implants
US8888841B2 (en) 2010-06-21 2014-11-18 Zorion Medical, Inc. Bioabsorbable implants
US8986369B2 (en) 2010-12-01 2015-03-24 Zorion Medical, Inc. Magnesium-based absorbable implants
US20130268055A1 (en) * 2012-03-07 2013-10-10 Orbusneich Medical, Inc. Medical device for implantation into luminal structures
WO2014066356A3 (en) * 2012-10-22 2014-06-19 Orbusneich Medical, Inc. Medical device for implantation into luminal structures
CN104869945A (en) * 2012-10-22 2015-08-26 奥巴斯尼茨医学公司 Medical device for implantation into luminal structures
US9566633B2 (en) 2012-11-15 2017-02-14 Vactronix Scientific, Inc. Stents having a hybrid pattern and methods of manufacture
WO2014078536A1 (en) * 2012-11-15 2014-05-22 Palmaz Scientific, Inc. Stents having a hybrid pattern and methods of manufacture
US10433989B2 (en) 2012-11-15 2019-10-08 Vactronix Scientific, Llc Stents having a hybrid pattern and methods of manufacture
USD887003S1 (en) 2012-11-15 2020-06-09 Vactronix Scientific, Llc Hybrid patterned stent device
US11701246B2 (en) 2012-11-15 2023-07-18 Vactronix Scientific, Llc. Stents having a hybrid pattern and methods of manufacture
US9980835B2 (en) 2013-10-22 2018-05-29 Orbusneich Medical Inc. Medical device for implantation into luminal structures incorporating corrugated structural elements

Also Published As

Publication number Publication date
JP5523700B2 (en) 2014-06-18
CN102309370A (en) 2012-01-11
ES2764992T3 (en) 2020-06-05
AU2006231559A1 (en) 2006-10-12
EP1871292A2 (en) 2008-01-02
US9592137B2 (en) 2017-03-14
EP1871292B1 (en) 2019-10-23
US20060247759A1 (en) 2006-11-02
WO2006108010A3 (en) 2009-04-16
CN102309370B (en) 2015-04-15
CN101484089B (en) 2015-11-25
EP1871292A4 (en) 2010-03-31
US20070208416A1 (en) 2007-09-06
CA2610108A1 (en) 2006-10-12
EP2505166A1 (en) 2012-10-03
HK1165257A1 (en) 2012-10-05
EP2505166B1 (en) 2017-07-12
CN102302390A (en) 2012-01-04
WO2006108010A2 (en) 2006-10-12
CN102302390B (en) 2016-05-25
US20140379066A1 (en) 2014-12-25
NZ563119A (en) 2011-02-25
JP2008544765A (en) 2008-12-11
CN101484089A (en) 2009-07-15
AU2006231559B2 (en) 2012-03-22
EP3613387B1 (en) 2023-01-11
EP3613387A1 (en) 2020-02-26
US7803180B2 (en) 2010-09-28
US7556644B2 (en) 2009-07-07
CA2610108C (en) 2014-03-25

Similar Documents

Publication Publication Date Title
US9592137B2 (en) Flexible stent
US20150148887A1 (en) Flexible devices
US7988723B2 (en) Flexible stent
JPH0572820B2 (en)
AU2012201649B2 (en) Flexible stent
US20150039072A1 (en) Flexible stent
AU2014201135B2 (en) Flexible stent
NZ588872A (en) Self expanding flexible stent comprising a helical strut member and multiple helical elements
AU2015255219A1 (en) Flexible devices
ES2937954T3 (en) flexible stent
MX2007012271A (en) Flexible stent

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION